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1. INTRODUCTION 
 Cancer is a group of more than 100 different diseases which is characterized by 
uncontrolled cellular growth, distant metastases and local tissue invasion (Kaufman et al., 
1996). Carcinogenesis is a multi-step process that includes initiation phase, promotion 
phase, conversion phase and finally progression phase. The growth of both normal and 
cancerous cells is genetically controlled by the balance or imbalance of oncogene, 
protooncogene and tumor suppressor gene. Multiple genetic mutations are required to 
convert normal cells to cancerous cells. Apoptosis and cellular senescence (aging) are 
normal mechanisms for cell death. Cancer cells are genetically unstable, which results in 
tumor masses of heterogeneous cells and makes the cancer a “moving target” for drug 
therapy. Existence of many different clones of cancer cells in most patients provides the 
rationale for use of cancer drugs in combination and is the likely reason for failure of 
cancer drug therapy to cure most patients with advanced cancer. 
 The goals of cancer treatment include cure, prolongation of life and relief of 
symptoms. Surgery and radiation therapy provide the best chance of cure for patients with 
localized cancers, but systemic treatment methods are required for systemic cancers. 
Long-term complications of cancer treatment, such as infertility, secondary malignancies, 
effects on physical or intellectual development and major organ damage, can negatively 
affect health and quality of life for cancer survivors. 
 Traditionally, cancer drugs were discovered through large-scale testing of synthetic 
chemicals and natural products against rapidly proliferating animal tumor systems, 
primarily murine leukemias (Chabner and Roberts, 2005). Most of the agents that are 
discovered in the first two decades of cancer chemotherapy (1950 to 1970) interacted 
with DNA or its precursors, thereby inhibiting the synthesis of new genetic material or 
causing irreparable damage to DNA. In recent years, the discovery of new agents has 
extended from the more conventional natural products such as paclitaxel and 
semisynthetic agents such as etoposide which targets the proliferative process. Initial 
success in characterizing unique tumor antigens and oncogenes has introduced new 
therapeutic opportunities in therapy. The bcr-abl translocation in chronic myelocytic 
leukemia (CML) encodes a tyrosine kinase which is essential to cell proliferation and 
survival. Inhibition of the kinase by imatinib (STI-571), a new molecularly targeted drug 
which has become the standard treatment for CML results in hematologic and cytogenic 
remission in the majority of patients. Similarly the targeted immunological approaches 
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use monoclonal antibodies against tumor-associated antigens such as the her-2/neu 
receptor in cancer cells (breast), which is in conjunction with cytotoxic drugs (Slamon et 
al., 2001).  
 Human beings have relied on natural products as a resource of drugs for past 
thousands of years. Plant-based drugs that have formed the basis of traditional medicine 
systems that have been used for centuries in many countries such as Egypt, China and 
India (Balandrin et al., 1993). Today plant-based drugs continue to play an essential role 
in human health care. It has been estimated by the World Health Organization that, about 
80% of the population of the world rely mainly on traditional medicines for their primary 
health care (Farnsworth et al., 1985). Natural products also play an important role in the 
health care of the remaining 20% people around the world, who mainly reside in 
developed countries. At present, at least 119 chemicals which are derived from 90 plant 
species, can also be considered as important drugs in one or more countries (Arvigo R  et 
al., 1993). 
 Plant secondary metabolites have proved to be an excellent reservoir of new medical 
compounds. Many anti-cancer agents have been isolated from various plant sources like 
Catharanthus roseus, Taxus brevifolia, Podophyllum species, Camptotheca acuminate, 
Betula alba, Cephalotaxus species, Curcuma longa, Erythroxylum pervillei, Centaurea 
schischkinii, Ipomoeca batatas and  many others. Still, scientists are attempting to explore 
the availability of anti-cancerous compounds in unexplored plant species. 
 
Carcinogenesis 
 The mechanism by which cancers occur is incompletely understood. A cancer or 
neoplasm, is thought to develop from a cell in which the normal mechanisms for control 
of growth and proliferation are altered. Current evidence supports the concept of 
carcinogenesis as a multistage process that is genetically regulated. Initiation is the first 
step in this process, which requires exposure of normal cells to carcinogenic substances. 
These carcinogens certainly produce genetic damage, if not repaired that results in 
irreversible cellular mutations. This mutated cell has an altered response to its 
environment and a selective growth advantage, providing the potential to develop into a 
clonal population of neoplastic cells. During the second phase known as promotion, 
carcinogens or other factors that alter the environment to favour the growth of the 
mutated cell population over normal cells. The primary difference between initiation and 
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A normal cell turns into a cancer cell because of one or more mutations in its DNA, 
which can be acquired or inherited. However, carcinogenesis is a complex multistage 
process which usually involves more than one genetic change as well as other epigenetic 
factors such as hormonal, carcinogens and tumour promoter effects etc. that do not 
themselves results in cancer but which can increase the chances that the genetic 
mutation(s) will eventually result in cancer. 
 There are two main categories of genetic change that are important.  
 
• The activation of proto-oncogenes to oncogenes. The Proto-oncogenes are genes that 
normally control cell division, differentiation and apoptosis, but can be converted to 
oncogenes. 
 
• The inactivation of tumour suppressor genes. The Normal cells contain genes which 
posses the ability to suppress malignant change-termed tumour suppressor genes 
(antioncogenes) and there is now good evidence that mutations of these genes results 
in many different type of cancers. The loss or lack of function of tumour suppressor 
genes can be an important event in carcinogenesis. 
 
THE SPECIAL CHARACTERISSTICS OF CANCER CELLS 
 
1. UNCONTROLLED PROLIFERATION 
Transformation of proto-oncogenes into oncogenes or inactivation of tumour 
suppressor genes can alter autonomy of growth on a cell and thus result in 
uncontrolled proliferation by producing changes in several cellular systems including: 
• Growth factors, signalling pathways and their receptors. 
• The cell cycle transducers, for example the cdk inhibitors or cyclin-dependent kinases 
(cdks), cyclins. 
• The apoptotic machinery that normally remove abnormal cells. 
• Telomerase expression. 
• Local blood vessels which are resulting from tumour-directed angiogenesis. 
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2. DEDIFFERENTIATION AND LOSS OF FUNCTION 
 The multiplication of normal cells in a tissue begins with division of the 
undifferentiated stem cells giving rise to its daughter cells. These daughter cells 
differentiate to become the mature cells of the relevant tissue that are ready to perform 
their functions. For example, when a fibroblasts mature, they can able to secrete and 
organise extracellular matrix and mature muscle cells are capable of contraction. The 
main characteristics of cancer cells is that they can dedifferentiate to varying degrees. 
 
3. INVASIVENESS 
 Normal cells are not found outside their 'designated' tissue of origin; for example, 
liver cells are not found in the bladder and pancreatic cells are not found in the testis. This 
is because, during differentiation and tissue or organ growth the normal cells develop 
certain spatial relationships with respect to each other and these are maintained by various 
tissue-specific survival factors that prevent apoptosis. In this way, any cells that escape 
accidentally lose these survival signals and die. Consequently, although the cells of the 
normal mucosal epithelium of the rectum proliferate continuously as the lining is shed, 
they remain as a lining of epithelium. A cancer of the rectal mucosa invades other tissues 
forming the rectum and may even invade the tissues of other organs in pelvic. Cancer 
cells not only lost, through mutation, the restraints can act on normal cells, but they also 
secrete enzymes (e.g. metalloproteinases) that break down the extracellular matrix that 
enables them to move around.  
 
4. METASTASES 
 Metastases are secondary tumours formed by cells that have been released from the 
initial or primary tumour and have reached other sites through blood vessels or 
lymphatics, or as a result of being shed into the body cavities. The metastases are the 
principal cause of mortality and morbidity in most cancers and cause a major problem for 
cancer therapy (Rang et al., 2007). 
 
CANCER TREATMENT MODALITIES 
 Choice of cancer treatment is influenced by several other factors, including the 
specific characteristics of the cancer, the overall condition and whether the goal of 
treatment is to cure cancer and keep the cancer from spreading or to relieve the symptoms 
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that are caused by cancer. One or more treatment modalities may be used to provide you 
with the most effective treatments. And it is common to use several treatment modalities 
together (concurrently) or in sequence with the goal of preventing reocurrence. This can 
referred to as multi-modality treatment of the cancer. Depending on these factors, you 
may receive one or more of the following 
 Surgery 
 Surgery is used to diagnose, determine its stage and to treat cancer. One of the 
common type of surgery that may be used to help with diagnosing cancer is a biopsy. 
When surgery is used for treatment of cancer and tissue that are adjacent to the cancer are 
typically removed.  
 
 Chemotherapy 
  Chemotherapy is any treatment involving the use of drugs to kill cancer cells. 
Cancer chemotherapy consist of single drugs or combinations of drugs and that can be 
administered through a vein, delivered orally in the form of a pill or injected into a body 
cavity. Chemotherapy is different from radiation therapy or surgery, the cancer-fighting 
drugs circulate in the blood to different parts of the body where the cancer may have 
spread and can kill or eliminate cancers cells at sites great distances from the original 
cancer site. Hence chemotherapy is considered a systemic treatment. 
 
 Radiation therapy 
Radiation therapy or radiotherapy uses high-energy rays to kill or damage cancer 
cells by preventing them from dividing and growing. Radiation therapy is an local 
treatment that are used to eliminate or eradicate visible tumors similar to surgery,.  
Radiation may be used to control or cure cancer or to relieve some of the symptoms 
caused by cancer.  
 
 Hormonal therapy 
Hormones are naturally occurring substances in the body that can stimulate the 
growth of hormone sensitive tissues such as the prostate gland or breast. When cancer 
arises in prostate or breast tissue, its growth and spread can also be caused by the body’s 
own hormones. Hence the drugs that blocks hormone production or change the way in 
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which hormones work or removal of organs that secrete hormones such as the testicles or 
ovaries are ways of fighting cancer. 
• Targeted therapy  
A targeted therapy is one that is designed to treat only the cancer cells and minimize 
damage to normal, healthy cells. Cancer treatments that “target” cancer cells may 
offer the advantage of reduced treatment-related side effects and improved outcomes. 
 
 Biological therapy 
Biological therapy is referred to by many terms that includes immunologic therapy, 
biotherapy or immunotherapy. Biological therapy is a type of treatment in which that 
uses the body’s own immune system to facilitate the killing of cancer cells. Types of 
biological therapy include interleukin, interferon, colony stimulating factors (cytokines), 
monoclonal antibodies and vaccines. 
 Personalized Cancer Care 
There is no longer a “one-size-fits-all” approach in cancer treatment. Among patients 
with the same type of cancer, the behavior of the cancer may vary and its response to 
treatment can vary. By knowing the reasons for this variation, researchers have begun to 
realize the need for more personalized cancer treatment. 
 
CHEMOTHERAPY 
 Paul Ehrlich introduced the term chemotherapy in 1907 to describe his important 
early studies of the tsetse fly–borne parasite, Trypanosoma brucei that causes African 
trypanosomiasis (sleeping sickness). The term chemotherapy initially referring to 
antiparasitic therapy now called more broadly to the use of any chemical compound that 
selectively acts on microbes, viral or cancer. Ehrlich had previously developed selective 
chemical stains for the microscopic examination of Mycobacterium tuberculosis and other 
microorganisms, using the coal-tar derivative dyes. He tested many of these organic 
compounds for their selective toxicity against trypanosomes but failed to find an effective 
nontoxic antischistosomal agent. Turning to the chemotherapy of syphilis, Ehrlich 
eventually discovered the arsenical compound salvarsan, which was both remarkably 
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nontoxic to humans and remarkably toxic against a number of treponemal diseases 
including syphilis and yaws. Ehrlich called salvarsan the magic bullet. 
 Humans were not the first to exploit the selective toxicity of chemicals. Many fungi 
and bacteria make toxic substances that kill or suppress the growth of competing 
microorganisms or facilitate infection of a host. Plants make a vast array of toxins for 
their self-defense. Exploitation of the selective toxicity of chemicals is an ancient and 
widely employed technique (Charles R Craig & Robert E Stitzel., 2004). 
 
The goals of chemotherapy 
 Treatments like radiation and surgery are considered as local treatments where they 
act only in one area of the body such as the lung, breast or prostate and usually target the 
cancer directly. Chemotherapy differs from radiation or surgery in that it’s almost always 
used as a systemic treatment. This means the drugs need to travel throughout the body to 
reach cancer cells wherever they are  
Ther 3 possible goals for chemotherapy treatment are: 
Cure: If possible, chemotherapy is used to cure the cancer which means that the cancer 
disappears and does not return. Hence, most doctors do not use the word “cure” except as 
a intention or possibility. Giving treatment that has a chance of curing a person’s cancer, 
the doctor may describe it as a treatment with curative intent. But there are no guarantees 
and the cure may be the goal, but it doesn’t always work out that way. It often takes many 
years to know wheather a person’s cancer is actually cured. 
Control: If cure is not possible, the goal may be to control the disease that is to shrink 
any cancerous tumors or stop the cancer from growing and spreading to other regions. 
This can help patient with cancer feel better and possibly live longer.  
Palliation: When the cancer is at an advanced stage, chemotherapy drugs can be used to 
relieve symptoms that are caused by the cancer. The only goal of a certain treatment is to 
improve the quality of life but not treat the disease, its called palliation or palliative 
treatment (Gullate et al., 2004). 
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Chemotherapy drugs work in various ways: 
Drugs act by preventing cell division - these are known as cytotoxic drugs.                                                 
• Targeting cancer cell's food source, hormones and enzymes that they require in order 
to grow. 
• Stopping the growth of new blood vessels that supplies to tumor. Researchers at the 
Johns Hopkins University School of Medicine in a study discovered how a whole 
class of commonly used chemotherapy drugs can destroy cancer by blocking blood 
vessel growth. 
• Triggering suicide of cancer cells - cell suicide is known medically as apoptosis. 
Patients may receive mono therapy or combination therapy: 
• Monotherapy - the patient is given just one drug. 
 
• Combination therapy - the patient receives more than one drug. 
Which type the patient receives will depend on the kind of cancer the patient has, region 
which is affected as well as some other health considerations.  
 
Chemotherapy given at different stages  
• Neo-adjuvant therapy - if the tumor size is large the surgeon may want to shrink it 
before surgery. This involves some pre-operative chemotherapy or radiotherapy. 
• Chemoradiation therapy - the chemotherapy is given in combination with radiation 
therapy/radiotherapy. 
• Adjuvant therapy – the chemotherapy which is given after surgery. The chemotherapy 
following surgery reduces the risk of death from operable pancreatic cancer by around 
30%, a UK study found. 
Cell cycle 
    An understanding of cell-cycle kinetics is essential for the proper use of antineoplastic 
agents. Many of the most effective cytotoxic agents damage DNA and their toxicity is 
greater during the DNA synthetic or S phase of the cell cycle. Others, such as the taxanes 
and vinca alkaloids block formation of a functional mitotic spindle in M phase. Human 
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neoplasms that are most susceptible to chemotherapy are those with a high percentage of 
cells undergoing division. Similarly the normal tissues that proliferate rapidly (e.g., bone 
marrow, intestinal epithelium and hair follicles) are most subject to damage by cytotoxic 
drugs, which often limits their usefulness. The slowly growing tumors with a small 
growth fraction (e.g., carcinomas of the colon or non–small cell lung cancer) often are 
less responsive to cycle-specific drugs. Understanding of cell-cycle kinetics and the 
controls of normal and malignant cell growth is crucial to the design of current 
therapeutic regimens and the search for new drugs 
 All living tissue is made up of cells. Cells reproduce and grow to replace cells that are 
lost through injury or normal wear and tear. The cell cycle is a series of steps where both 
normal cells and cancer cells go through in order to form new cells. The cell cycle has 5 
phases which are labeled below using numbers and letters. Since reproduction of cells 
happens over and over again, the cell cycle is shown as a circle. All these steps lead back 
to the resting phase (G0), which is the starting point. After a cell reproduces, the two new 
daughter cells are identical. Each cells made from the first cell can go through this cell 
cycle again when new cells are needed (Nordqvist C., 2009). 
All cancer cells do not proliferate faster than normal cells; some cancer cells 
reproduce more rapidly and others are more indolent. Many anticancer drugs target 
rapidly-proliferating cells (both normal and cancerous cells), and these agents may act at 
selective or multiple sites of the cell cycle. Agents with major activity in a particular 
phase of the cell cycle are known as cell-cycle phase–specific agents. The antimetabolites 
exert their major effect during the S phase. Cell-cycle phase–specific agents may also be 
active to a lesser extent in other phases of the cycle. Cell-cycle phase–nonspecific agents 
are those with significant activity in multiple phases. The alkylating agents such as 
nitrogen mustard are examples. 
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Fig: 2 - The cell cycle and the relationship of antitumor drug action to the cycle. 
G0 phase (resting stage): The cell that has not yet started to divide, spend most of their 
lives in this phase. Depending on the type of cell, resting stage can last from a few hours 
to a few years. When a cell gets the signal to reproduce, it moves onto the next phase, G1. 
G1 phase: During this phase, the cell starts making more proteins and growing larger , so 
the new cells will be of normal size. This G1 phase lasts about 18 - 30 hours. 
S phase: In the S phase, the chromosomes containing the genetic code (DNA) are copied 
so that both of the new daughter cells formed will have strands of DNA that are matching. 
This phase lasts about 18 to 20 hours. 
G2 phase: In the G2 phase, the cell checks the DNA and gets ready to start splitting into 
two cells. This phase lasts about 2 to 10 hours. 
M phase (mitosis): In this phase, which lasts only 30 to 60 minutes, the cell actually 
splits into 2 new cells. 
The cell cycle is important because many chemotherapy drugs work only on cells that 
are actively reproducing (not cells that are in the G0, resting phase). Some 
chemotherapeutic drugs specifically attack cells in a particular phase of the cell cycle (the 
S or M phases). Knowing how these drugs work helps oncologists to predict which drugs 
are likely to work well when comparing to others. Oncologists can also plan how often 
doses of each drug need to be given based on the timing of the cell phases. 
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Chemotherapy drugs cannot tell the difference between cancer cells and reproducing 
cells of normal tissues (those that are replacing worn-out normal cells). Because of that 
normal cells are damaged and this results in side effects of therapy. Each time 
chemotherapy is given, it involves trying to find a balance between sparing the normal 
cells (to lessen unwanted side effects) and destroying the cancer cells (in order to cure or 
control the disease). 
 
SIDE EFFECTS OF CHEMOTHERAPY 
Most people immediately link chemotherapy with uncomfortable side effects. 
However, over the last twenty years side-effect management has improved considerably. 
Many side effects that were once inevitable in an treatment can be well controlled or 
either prevented today. However, there is no reliable way to predict how patients may 
react to different drugs in chemotherapy. Some patients experience very mild side-effect, 
while some people will report various symptoms, others will have none at all. 
 Depending on the type of treatment and cancer, chemotherapy might have a bigger 
impact on the patient's work status than radiation therapy. According to researchers at the 
Dana-Farber Cancer-Institute women with breast cancer receiving chemotherapy appear 
more likely than those treated with radiotherapy to experience a change in work status. 
Below is a list of the most commonly reported side effects:  
Nausea and vomiting 
Over half of all patients receiving chemotherapy will experience nausea and vomiting. 
Doctors will usually prescribe anti-emetics. These drugs need to be taken even when 
symptoms have gone since they will prevent them from coming back. If the anti-emetics 
drugs do not work the patient should contact doctor who may switch to another anti-
emetic.  
 
Alopecia (Hair loss) 
  Some chemotherapy medications cause hair loss while others do not. If treatment 
starts hair does start to fall out, this will usually happen in a few weeks. In some 
occasions the hair will become more brittle and thinner (without falling out). In any part 
of the body hair loss can occur. Although hair loss has no physical health consequences, it 
Evaluation of the chemoprotective activity of 70% methanolic extract of Gmelina arborea stem bark against 
cyclophosphamide induced toxicity 
 
RVS College of Pharmaceutical Sciences, Dept. Of Pharmacology, Sulur, Coimbatore.  Page 13 
 
may cause embarrassment and distress for some people. Comparing to the men the 
psychological impact tends to be greater among women. 
Fatigue 
        Most patients will experience some degree of fatigue on receiving chemotherapy. 
This may be a general feeling that exists most of the day, or only appear after certain 
activities. Oncologists say patients need to make sure that, not to perform tasks which are 
overtiring and they get plenty of rest. While light exercise has been shown to help patients 
and it is important to keep the activities 'light'. 
Hearing impairment (deafness, ototoxicity) 
 Scientists from Oregon Health & Science University reported that deafness as a side 
effect of chemotherapy has long been underreported by the medical community, because 
a well-known classification system doctors use for reporting toxicities in patients does not 
consider high-frequency hearing loss, allowing the magnitude of ototoxicity (hearing 
damage) in children treated with platinum agents to be miscalculated. 
Neutropenia (low white blood cells) - Susceptibility to infections 
When receiving chemotherapy the immune system will be weakened because the 
white blood cell count will go down. White blood cells form a part of our immune system 
as they fight infection. Because of that, patients become more susceptible to 
infections. Some patients will be prescribed antibiotics which may reduce their risk of 
developing infections. 
Thrombocytopenia (low blood platelet count) - Blood clotting problems 
Chemotherapy may lower the patient's platelet count in blood. A platelet is a type of 
blood cell which helps the blood to clot (coagulate). Coagulation is essential, otherwise 
bleeding does not stop. Decreasing blood platelet counts linked to chemotherapy is a risk, 
but less severe than lower white or red blood cell counts. If patient with low platelet count 
will bruise more easily, patient will be more likely to have bleeding gums and nosebleeds, 
and if patient made a cut in a body, it may be harder to stop the bleeding. Patient's whose 
blood platelet counts fall too low will need a blood transfusion. 
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 Anemia (low red blood-cell count) 
  As well as lowering in white blood cell count, chemotherapy results in lowering 
patient’s red blood cell count. Organs and tissues inside your body get their oxygen from 
the red blood cells. If patient’s red blood cell count goes down, too many parts of body 
will not get enough oxygen and will develop anemia in patients. 
Anemia linked to chemotherapy requires immediate attention. To bring the red blood 
cell count back up immediately a blood transfusion will be done. Erythropoietin (EPO) is 
a drug that makes the body produce more red blood cells. 
 Mucositis (inflammation of the mucous membrane) 
 Chemotherapy attacks rapidly dividing cells such as bone marrow cells, blood cells, 
and cells of the mucous membranes that line the digestive system - this includes the 
mouth, esophagus, stomach, intestines and the rectum to the anus. Chemotherapy cause 
damage and even destroy some of those mucous membrane cells.  
Oral Mucositis (in the mouth) - patients more commonly experience symptoms in 
their mouth. If symptoms do appear, they will usually appear about 7 to 10 days after 
treatment starts. The inside of the mouth, patient may feel like sunburn some people say it 
feels as if the area had been scalded. Ulcers often appear on the the tongue, lining of the 
mouth and sometimes around the lips. The rigorousness of symptoms is closely linked to 
the strength of the chemotherapy dose. 
Loss of appetite 
 Loss of appetite is a common side effect of chemotherapy. It is possible that the 
cancer itself or chemotherapy, affects the body's metabolism. If appetite come back when 
the treatment is finished, means that the loss of appetite is just due to the chemotherapy  - 
although this may sometimes take a few weeks. The severity of appetite and consequent 
weight loss depends on the type of cancer and chemotherapy treatment. 
 Nails and skin 
 Chemotherapy can sometimes cause sore and dry skin. Nails may also become brittle 
and flaky. The skin sometime become more sensitive to sunlight. It is very important to 
protect pateint from too much sunlight exposure. This includes staying out of the sun 
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during peak times of the day, make use of sun blocks and wearing clothes that provide 
maximum protection.  
Cognitive problems 
 About one fifth of patients undergoing chemotherapy report some kind of cognitive 
problems including memory, attention and thinking. This sometimes can have an impact 
on daily tasks. 
Symptoms may include: 
• Shorter attention span, attention problems, concentration and focus . 
• Comprehension and understand problems. 
• Memory problems, especially the short-term memory. 
• Organizational skills may be affected. 
• Judgment and reasoning problems. 
• Multitasking problems (performing/thinking about several things at the same time). 
• Mood swings. 
Libido (sex drive) and fertility 
Chemotherapy may result in a lower sex drive (less interest in sex) for a significant 
proportion of patients. This is temporary and usually returns after treatment is completed.  
Chemotherapy may also damage men's sperm depending on the type of medication 
administered. Some women may become infertile. In most cases - though not all - fertility 
returns after treatment is over. 
Bowel movement problems (diarrhoea or constipation) 
 There is a risk of diarrhoea sometimes when damaged cells in the intestinal tract are 
rapidly expelled from the body. For chemotherapy patients constipation is also a possible 
risk. 
Depression 
 The risk of developing depression is already higher for patients with cancer. It is 
normal to feel anxious, distressed, stressed and sad - especially if you are concerned about 
what the future holds and whether treatment is going to be effective. 
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Different types of chemotherapy drugs 
 Chemotherapy drugs can be divided into several groups based on factors such as their 
chemical structure, how they work and their relationship to another drug. Some drugs act 
in more than one way in our body and they may belong to one or more group. 
Understanding how the drug works is important in predicting side effects of drug. This 
helps docter’s to decide which drugs are likely to work well compare to other. If one or 
more drug are using, this information also helps them to plan exactly when each of the 
drugs should be given to patient (in which order and how often) (Mori T et al., 2006). 
 
Classification of the Anticancer Drugs 
I. Alkylating agents 
 A. Nitrogen mustards 
                1. Mechlorethamine hydrochloride (Mustargen, HN2, nitrogen mustard) 
                2. Cyclophosphamide (Cytoxan) 
                3. Chlorambucil (Leukeran) 
                4. Melphalan (Alkeran, L-PAM, L-phenylalanine mustard) 
                5. Ifosfamide (Ifex) 
 B. Alkyl sulfonates 
                1. Busulfan (Myleran) 
 C. Nitrosoureas 
                1. Carmustine (BCNU, BiCNU) 
                2. Lomustine (CCNU, CeeNU) 
                3. Semustine (methyl-CCNU) 
                4. Streptozocin (Zanosar, streptozotocin) 
 D. Ethylenimines 
                1. Thiotepa 
      E. Triazenes 
                1. Dacarbazine (DTIC-Dome) 
II. Antimetabolites 
 A. Folate antagonist 
               1. Methotrexate (Folex, Mexate) 
      B. Purine analogues 
               1. Thioguanine (6-TG, 6-thioguanine) 
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               2. Mercaptopurine (6-MP, Purinethol) 
               3. Fludarabine (Fludara) 
               4. Pentostatin (deoxycoformycin, Nipent) 
               5. Cladribine (2-chloro-deoxyadenosine, Leustatin) 
 C. Pyrimidine analogues 
               1. Cytarabine (cytosine arabinoside, Cytosar-U, ara-C) 
             2. Fluorouracil (5-FU, 5-fluorouracil) 
III. Antibiotics 
     A. Anthracyclines 
             1. Doxorubicin hydrochloride (Adriamycin) 
             2. Daunorubicin (daunomycin, Cerubidine) 
             3. Idarubicin (Idamycin) 
     B. Bleomycins 
             1. Bleomycin sulfate (Blenoxane) 
     C. Mitomycin (mitomycin C, Mutamycin) 
     D. Dactinomycin (actinomycin D, Cosmegen) 
     E. Plicamycin (Mithracin) 
IV. Plant-derived products 
    A. Vinca alkaloids 
            1. Vincristine (Oncovin) 
            2. Vinblastine (Velban) 
   B. Epipodophyllotoxins 
            1. Etoposide (VP-16, Vepesid) 
            2. Teniposide (VM-26, Vumon) 
   C. Taxanes: paclitaxel( Taxol) 
V. Enzymes 
    A. L-Asparaginase (Elspar) 
VI. Hormonal agents 
     A. Glucocorticoids 
     B. Estrogens, antiestrogens 
            1. Tamoxifen citrate (Nolvadex) 
            2. Estramustine phosphate sodium (Emcyt) 
     C. Androgens, antiandrogens 
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            1. Flutamide (Eulexin) 
     D. Progestins 
 E. Luteinizing hormone–releasing hormone (LH-RH) antagonists 
            1. Buserelin (Suprefact) 
            2. Leuprolide (Lupron) 
 F. Octreotide acetate (Sandostatin) 
VII. Miscellaneous agents 
   A. Hydroxyurea (Hydrea) 
   B. Procarbazine (N-methylhydrazine, Matulane, Natulan) 
   C. Mitotane (o,p´-DDD, Lysodren) 
   D. Hexamethylmelamine (HMM) 
   E. Cisplatin (cis-platinum II; Platinol) 
   F. Carboplatin (Paraplatin) 
   G. Mitoxantrone (Novantrone) 
VIII. Monoclonal antibodies 
IX. Immunomodulating agents 
   A. Levamisole (Ergamisol) 
   B. Interferons 
         1. Interferon alfa-2a (Roferon-A) 
         2. Interferon alfa-2b (Intron A) 
   C. Interleukins: aldesleukin (interleukin-2, IL-2, Proleukin) 
X. Cellular growth factors 
 A. Filgrastim (G-CSF; Neupogen) 
 B. Sargramostim (GM-CSF, Leukine, Prokine) 
 
(Proprietary (italics) and other names are given in parentheses). 
(Charles & Robert., 2004) 
 
ALKYLATING AGENTS 
 Alkylating agents are compounds that are capable of introducing alkyl groups into 
nucleophilic sites on other molecules through the formation of covalent bonds. These 
nucleophilic targets for alkylation include the sulfhydryl, phosphate, amino, hydroxyl, 
Evaluation of the chemoprotective activity of 70% methanolic extract of Gmelina arborea stem bark against 
cyclophosphamide induced toxicity 
 
RVS College of Pharmaceutical Sciences, Dept. Of Pharmacology, Sulur, Coimbatore.  Page 19 
 
carboxyl and imidazole groups that are present in macromolecules and low-molecular-
weight compounds within cells. In alkylating agents, the main step is the formation of a 
carbonium ion, which is a carbon atom with only 6 electrons in its outer shell. These type 
of ions are highly reactive and react instantaneously with an electron donor such as an 
amine, sulfhydryl or hydroxyl group. Most of the cytotoxic anticancer alkylating agents 
are bifunctional in action, i.e. they have two alkylating groups. 
 The most common binding site for alkylating agents is the seven-nitrogen group of 
guanine. These covalent interactions result in cross-linking between two DNA strands or 
between two bases in the same strand of DNA. Reactions between DNA and RNA and 
between drug and proteins may also occur, but that results in cell death because the 
interlinked strands do not separate as required. Because the alkylating agents can damage 
DNA during any phase of the cell cycle, they are not cell-cycle–phase specific. However, 
their greatest effect is seen in rapidly dividing cells. As a class alkylators are cytotoxic, 
carcinogenic, mutagenic, teratogenic and myelosuppressive. Resistance to these agents 
can occur from increased DNA repair capabilities, from accelerated exit from or 
decreased entry into cells, from increased inactivation of the agents inside cells, or from 
lack of cellular mechanisms to result in cell death following DNA damage. They react 
with water and are inactivated by hydrolysis, making spontaneous degradation an 
important component of their elimination (Morrow and Harris ., 2000). 
Toxicities of Alkylating Agents 
• Bone Marrow Toxicity 
 The alkylating agents differ in their patterns of antitumor activity and in the sites and 
severity of their side effects. Most of them cause dose-limiting toxicity to bone marrow 
elements and intestinal mucosa (to a lesser extent). Most alkylating agents including 
chlorambucil, nitrogen mustard, melphalan, cyclophosphamide and ifosfamide cause 
acute myelosuppression with a lower level of the peripheral blood granulocyte count at 6 
- 10 days and recovery in 14 - 21 days. Cyclophosphamide has lesser effects on peripheral 
blood platelet counts than do the other agents. Carmustine and other 
chloroethylnitrosoureas cause delayed and prolonged suppression of both granulocytes 
and platelets, reaching the low value 4 to 6 weeks after drug administration and reversing 
slowly thereafter. Busulfan suppresses all blood elements, particularly stem cells and may 
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produce a prolonged and cumulative myelosuppression lasting months or even years. For 
this reason, it is used as a preparative regimen in allogenic bone marrow transplantation.       
 Both humoral and cellular immunity are suppressed by alkylating agents, which have 
been used to treat various autoimmune disorders. Immunosuppression can be reversible at 
doses used in most anticancer protocols. 
• Mucosal Toxicity 
In addition to effects on the hematopoietic system, alkylating agents are highly toxic 
to dividing mucosal cells, leading to oral mucosal ulceration and intestinal stripping. In 
high-dose chemotherapy protocols associated with bone marrow reconstitution, the 
mucosal effects are particularly significant, as they predispose to bacterial sepsis arising 
from the gastrointestinal tract. In these protocols, cyclophosphamide, thiotepa and 
melphalan have the advantage of causing less mucosal damage than the other agents. In 
high-dose protocols, however a number of additional toxicities become limiting. 
• Neurotoxicity 
CNS toxicity is manifest in the form of nausea and vomiting, particularly after 
intravenous administration of nitrogen mustard or BCNU. High-dose busulfan may cause 
seizures; in addition, it accelerates the clearance of an antiseizure medication, phenytoin. 
Ifosfamide is the most neurotoxic of this class of agents, producing altered mental status, 
generalized seizures, coma and cerebellar ataxia. These side effects have been linked to 
the release of chloroacetaldehyde from the phosphate-linked chloroethyl side chain of 
ifosfamide.  
• Other Organ Toxicities 
While mucosal and bone marrow toxicities occur predictably and acutely with 
conventional doses of these drugs, other organ toxicities may occur after prolonged or 
high-dose use; these effects can appear after months or years of therapy and may be 
irreversible and even lethal. Usually after several months of treatment all alkylating 
agents causes pulmonary fibrosis. Particularly those employing busulfan or BCNU in 
high-dose regimens, vascular endothelial damage may result in veno-occlusive disease 
(VOD) of the liver, which is an fatal side effect that is successfully reversed by the 
investigational drug defibrotide (Richardson., 2003). The ifosfamide and nitrosoureas 
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after multiple cycles of therapy may lead to renal failure. Cyclophosphamide and 
ifosfamide release a urotoxic and nephrotoxic metabolite called acrolein, which causes a 
severe hemorrhagic cystitis. Ifosfamide in high doses for transplant causes a chronic and 
often irreversible renal toxicity. Proximal and less commonly distal tubules may be 
affected, with difficulties in Mg2+ and Ca2+ reabsorption, renal tubular acidosis and 
glycosuria. Nephrotoxicity can be correlated with the total dose of drug received and 
increases in frequency in children less than 5 years of age. The syndrome has been 
attributed to acrolein and/or chloroacetaldehyde excreted in the urine (Skinner, 2003).  
   The more unstable alkylating agents (particularly mechlorethamine and the 
nitrosoureas) have strong vesicant properties, damage veins with repeated use and if 
extravasated, produce ulceration. Most alkylating agents cause alopecia. Alkylating 
agents have toxic effects on the female and male reproductive systems, causing an often 
permanent amenorrhea, particularly in perimenopausal women, and an irreversible 
azoospermia in men. 
• Leukemogenesis 
As a class of drugs, the alkylating agents are highly leukemogenic in nature. Acute 
nonlymphocytic leukemia, often associated with partial or total deletions of chromosome 
5 or 7, peaks in incidence about 4 years after therapy and may affect up to 5% of patients 
treated on regimens containing alkylating drugs (Levine and Bloomfield., 1992). It often 
is preceded by a period of anemia or neutropenia and bone marrow morphology 
consistent with myelodysplasia. Methylating agent procarbazine and Melphalan, the 
nitrosoureas have the greatest propensity to cause leukemia, where as it is less common 
with cyclophosphamide. 
CLINICAL PHARMACOLOGY 
      Nitrogen Mustards 
Nitrogen mustards are related to the 'mustard gas' used during the First World War; their 
basic formula (R-N-bis-(2-chloroethyl)). In the body, each 2-chloroethyl side-chain 
undergoes an intramolecular cyclisation with the release of a Cl-. The highly reactive 
ethylene immonium derivative so formed can interact with DNA and other molecules 
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CYCLOPHOSPHAMIDE 
 
Cyclophosphamide Monohydrate  
Physico –chemical properities 
Table : 1- Physio-chemical properties of cyclophophamide 
 
 Cyclophosphamide is probably the most commonly used alkylating agent. 
Cyclophosphamide administration results in the formation of cross-links within DNA due 
 
Molecular Formulae 
 
C7H15C12N2O2P.H2O 
 
Chemical Name 
2H-1,3,2-Oxazaphosphorin-2- amine,N,N-bis (2-
chloroethyl) tetrahydro,2- oxide, monohydrate 
 
Colour 
 
fine white crystalline powder. 
 
Odour 
 
Odourless 
 
solubility 
 
      soluble in water, saline, ethanol. 
 
Melting point 
 
49C-51C 
 
Storage temperature 
 
2C- 8C 
 
Water solubility 
 
40g/L 
 
Sensitivity 
 
Light and moisture sensitive 
 
Hazard Class 
 
6.1 
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to a reaction of the two chloroethyl moieties of cyclophosphamide with adjacent 
nucleotide bases. Cyclophosphamide must be activated metabolically by microsomal 
enzymes of the cytochrome P450 system before ionization of the chloride atoms and 
formation of the cyclic ethylenimmonium ion can occur. It is inactive until metabolised in 
the liver by the P450 mixed function oxidases . It has a pronounced effect on lymphocytes 
and can also be used as an immunosuppressant. It is usually given orally or by 
intravenous injection but may also be given intramuscularly.  
 
Mechanism of action  
 Cyclophosphamide undergoes metabolism to several intermediates with alkylating 
activity. The principal metabolites identified are phosphoramide mustard and acrolein. 
Phosphoramide mustard can undergo dephosphoramidation to yield nornitrogen mustard, 
which also has alkylating activity. Metabolites of cyclophosphamide can interact with 
proteins and DNA, resulting in the formation of adducts.  A minor pathway results in 
dechloroethylation and the formation of 2-dechloroethylcyclophosphamide and another 
alkylating agent, chloroacetaldehyde (Balu et al., 2002). The other compounds such as          
4-ketocyclophosphamide and propionic acid derivative are relatively non-toxic and are 
the major urinary metabolites of cyclophosphamide in several species (IARC., 1981). 
Important toxic effects are nausea, vomiting, haemorrhagic cystitis and bone marrow 
depression. This last effect is caused by the metabolite acrolein and can be ameliorated by 
increasing fluid intake and administering compounds that are sulfhydryl donors, such as 
mesna  (sodium-2-mercaptoethane sulfonate) or N-acetylcysteine.  These compounds 
interact specifically with acrolein, forming a non-toxic compound.  
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Fig : 3-Metabolism of cyclophosphamide ( Rang et al., 2007). 
 
Single-Agent Dosage 
3.5–5 mg/kg/d orally for 10 days; 1 g/m2 IV as single dose 
Major uses 
Cyclophosphamide is used in the treatment of chronic lymphocytic leukaemia, 
lymphomas, soft tissue and osteogenic sarcoma, and solid tumours. It is given orally or 
intravenously. 
 (a) Hodgkin lymphoma 
(b) Non-Hodgkin lymphoma 
(c) Multiple myeloma 
(d) Leukaemia 
(e) Cutaneous T-cell lymphoma 
(f) Neuroblastoma 
(g) Cancer of the ovary 
(h) Retinoblastoma 
(i) Cancer of the breast 
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(j) Small cell cancer of the lung 
(k) Sarcoma 
 
Major side effects 
Hemorrhagic cystitis 
Moderately emetogenic: worse with high doses; 
Nausea may be delayed 12–24 hours; 
Myelosuppression; 
Alopecia; 
SIADH, typically with high doses (>2 g/m2);  
Secondary malignancies (bladder cancers, acute leukemia); 
Infertility, sterility. 
 
CHEMOPROTECTIVE AGENTS 
 Chemoprotective agents are the drugs that are used with certain types of 
chemotherapy to protect the body from or minimize the side effects of the chemotherapy. 
Chemoprotective agents include amifostine, mesna and dexrazoxane.  
 Amifostine – Approved by the FDA in 1985, amifostine helps reduce the level of 
renal injury in some cancer patients treated with chemotherapy. Amifostine 
prevents cyclophosphamide (DNA-binding drugs), as well as drugs like cisplatin( which 
contain platinum) from binding to cells. Amifostine actually makes use of extracellular 
conditions such as higher pH, alkaline phosphatase activity and better vascular delivery of 
the drug to normal tissue, in order to protect normal tissue, while not extending this same 
type of defense to cancer cells. Amifostine is not an active drug on its own and instead is 
converted into an active metabolite inside cells.  
 
  Mesna – Approved by FDA in 1988, mesna is used to decrease bladder irritation 
(hemorrhagic cystitis) caused by certain high-dose chemotherapy protocols. In general 
these medications do not eliminate side effects. Instead, they protect the body from some 
of the potentially serious side effects. These drugs also posses side effects of their own so 
they are used only with specific types of chemotherapy treatment or when the benefit 
clearly is greater than the risk. 
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Dexrazoxane – Approved by the FDA in 1995, use of dexrazoxane has resulted in a 
significant decrease in cardiac events in cancer patients undergoing certain chemotherapy 
treatments. Dexrazoxane is another such chemoprotective drug which is particularly well-
suited to keep anthracycline antibiotics from damaging cardiac tissue. Anthracyclines can 
able to disrupt certain receptors in heart tissue, cause accumulations of cytotoxic 
metabolites and promote free radical formation, which is why these drugs are not used to 
treat normal infections, despite being antibiotics.  
  
 Today’s chemoprotective drugs which are usually administered with a specific type of 
chemotherapy drug; for example, Mesna which is used along with oxazophosphorines 
class of drugs. Mesna binds to the toxic metabolites of this class of chemotherapy drugs, 
helping to prevent urogenital problems and bladder inflammation.  
 Another chemoprotective drug used to reduce the side effects of cisplatin is N-
Acetylcysteine(NAC).In clinical trials, N-Acetylcysteine given up to 2 hours after 
administration of cisplatin, it reversed cytotoxic damage to tumor cell lines and prevented 
programmed cell death. N-Acetylcysteine seems to prevent cisplating binding 
mitochondrial and cellular receptors which normally begin the process of apoptosis. Since 
this drug(N-Acetylcysteine) does not cross the blood-brain barrier, it could be used in 
patients with brain cancer to protect many organs from damage without reducing the 
tumor-killing properties of the cisplatin. 
 Chemoprotective agents are still a new field of study and research will likely yield 
agents with greater selectivity for normal tissue, as well as the ability to protect a larger 
number of tissue types. Nanoparticle delivery may also assist in minimizing the side 
effects of chemotherapy. 
OXIDATIVE STRESS 
Oxidative stress reflects an imbalance between the systemic manifestation of reactive 
oxygen species and a biological system's ability to readily detoxify the reactive 
intermediates or to repair the resulting damage. Production of reactive oxygen species is a 
particularly destructive aspect of oxidative stress. Such species include peroxides and free 
radicals. Some of the less reactive of these species (such as superoxide) can be converted 
by oxidoreduction reactions with transition metals or other redox cycling compounds 
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(including quinones) into more aggressive radical species that can cause extensive 
cellular damage (Valko M et al., 2005). 
Oxidative stress is well known to be involved in the pathogenesis of lifestyle-related 
diseases including hypertension, atherosclerosis, ischemic diseases, diabetes mellitus and 
malignancies. Oxidative stress can be defined as harmful because oxygen free radicals 
attack biological molecules such as DNA, lipids and proteins. However, oxidative stress 
also has a useful role in physiologic adaptation and in the regulation of intracellular signal 
transduction. It can cause disruptions in normal mechanisms of cellular signaling. 
Therefore, a more useful definition of oxidative stress may be a state where oxidative 
forces exceed the antioxidant systems due to loss of the balance between them. The  
various biomarkers that can be used to assess oxidative stress in vivo have been attracting 
interest of scientists because of the accurate measurement of such stress is necessary for 
investigation of its role in lifestyle diseases as well as to evaluate the efficacy of 
treatment. Many markers of oxidative stress have been proposed, including lipid 4-
hydroxynonenal, hydroperoxides, isoprostan, ubiquinol-10 and 8-hydroxyguanine. 
Oxidative stress not only has a cytotoxic effect, but also plays an important role in the 
modulation of messengers that regulate essential cell membrane functions, which are vital 
for survival. It affects the intracellular redox status, leading to the activation of protein 
kinases, including a series of receptor and non-receptor tyrosine kinases, protein kinase C 
and the MAP kinase cascade and hence induces various cellular responses. These protein 
kinases play an important role in cellular responses such as activation, proliferation and 
differentiation, as well as various other functions. Oxidative stress can influence many 
biological processes such as apoptosis, inflammatory reactions and viral proliferation. In 
these processes, gene transcription factors such as nuclear factor-_B (NF-_B) and 
activator protein-1 (AP-1) act as oxidative stress sensors through their own oxidation and 
reduction cycling. This type of chemical modification of proteins by oxidation and 
reduction is called reduction-oxidation (redox) regulation (Toshikazu Yoshikawa and 
Yuji Naito., 2002). 
Oxidative stress is now thought to make a significant contribution to all inflammatory 
diseases (arthritis, glomerulonephritis, vasculitis, lupus erythematosus, adult respiratory 
distress syndrome), ischemic diseases (stroke, heart disease, intestinal ischemia), 
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hemochromatosis, acquired immunodeficiency syndrome (AIDS), emphysema, organ 
transplantation, hypertension, gastric ulcers and preeclampsia, neurologic diseases 
(Alzheimer’s disease, Parkinson disease, multiple sclerosis, amyotrophic lateral 
sclerosis), muscular dystrophy, smoking-related diseases, alcoholism and many others. 
The reason that overproduction of free radicals is a feature of such a broad spectrum of 
diseases derives from the fact that oxidative metabolism is a necessary part of every cell’s 
metabolism. If a cell that is sick or injured in any way that results in mitochondrial injury 
(leaky membranes, calcium influx and so forth), then increased production of superoxide 
is likely to result (Joe M Mc Cord et al., 2000). 
Reactive Oxygen Species are generated by a number of pathways. Most of the 
oxidants that are produced by cells occur as: 
• Oxidative burst from phagocytes (white blood cells) as part of the mechanism by which 
bacteria and viruses are killed, thereby foreign proteins (antigens) are denatured. 
 • A consequence of normal aerobic metabolism: approximately 90% of the oxygen 
utilized by the cell is consumed by the mitochondrial electron transport system. 
• Xenobiotic metabolism, i.e., detoxification of toxic substances.  
 
ANTI OXIDANTS 
 
 Oxidation is a chemical reaction that transfers electrons or hydrogen from a substance 
to an oxidizing agent. An antioxidant is a molecule that inhibits the oxidation of other 
molecules. Oxidation reactions can result in the production of free radicals and these 
radicals can start chain reactions. When the chain reaction starts in a cell, it can cause 
damage or death to the cell. Antioxidants terminate these type of chain reactions by 
inhibiting other oxidation reactions and removing free radical intermediates. They do this 
by being oxidized themselves, so antioxidants are often reducing agents such as ascorbic 
acid, asthiols or polyphenols (Sies and Helmut., 1997). Antioxidants are capable of 
stabilising or deactivating free radicals before they attack cells and are critical for 
maintaining  optimum cellular and systemic health and well being .There are mainly three 
types of antioxidants.  
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 A: Enzymes  
 Antioxidant enzymes are antioxidants that can be uniquely synthesized in the human 
body (eg. Superoxide dismutase, catalase and peroxiredoxins). They are made from the 
protein and minerals in the food we eat.  
 SOD is present in both inside and outside cell membranes, it is one of the body’s 
primary internal anti-oxidant defenses and plays a important role in reducing the 
oxidative stress implicated in atherosclerosis and other life-threatening diseases. Humans 
have three genes encoding superoxide dismutases (SOD), which localize in the 
mitochondria, the cytosol, or the extracellular spaces. These genes are derived from two 
ancestral genes. One gene gave rise to the copper-and-zinc– containing enzymes; the 
other gave rise to the manganese- or iron containing enzymes. The SODs catalyze the 
reaction: 
     O2 • -  + O2 • -  +  2H+                         3H2O2  +  O2  
 This dismutation or disproportionation reaction makes use of the fact that superoxide 
is both an oxidant and a reductant, eager to get rid of its extra electron or to take on 
another electron. The enzyme uses one superoxide radical to oxidize another. Catalases 
work in much the same way, because hydrogen peroxide can be a weak reductant as well 
as a fairly strong oxidant. It is a very important enzyme in protecting the cell from 
oxidative damage by reactive oxygen species (ROS).  It catalyzes the decomposition 
of hydrogen peroxide to water and oxygen (Chelikani P et al., 2004). 
H2O2   +   H2O2                         H2O    +    O2 
 In higher organisms, glutathione peroxidases appear to have largely supplanted the 
need for catalase. These enzymes use NADPH as the reducing species for hydrogen 
peroxide: 
     NADPH +  H+  +  H2O2                       2H2O  +  NADP+ 
 They can reduce lipid peroxides as well as hydrogen peroxide and are very important 
enzymes in the prevention of lipid peroxidation to maintain the structure and function of 
biologic membranes. Glutathione peroxidise act as catalysts in the liver facilitating 
reactions that render toxins less harmful (Umulis D M et al., 2005). 
B: Vitamins  
 Vitamins cannot be created in our bodies. It need to be supplemented every day 
without any fail. The typical antioxidant vitamins are vitamins A, C, E, and M (folic acid) 
etc.  
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C: Phytochemicals  
 Phytochemicals are antioxidants that are present in many plants to protect themselves 
and it has been found that if people ingest these plants the phytochemicals present in it 
work as antioxidants within our bodies, eg: blue berry, tomato, spinach. 
            The body relies on several endogenous defense mechanisms to help protect 
against free radical-induced cell damage. The antioxidant enzymes – glutathione 
peroxidase, catalase and superoxide dismutase (SOD) – metabolize oxidative toxic 
intermediates and require micronutrient cofactors such as iron, selenium, zinc, copper and 
manganese for optimum catalytic activity. Inadequate dietary intake of these trace 
minerals has been suggested that they may compromise the effectiveness of these 
antioxidant defense mechanisms (Duthie and Brown .,1994). Glutathione is an important 
water-soluble antioxidant which is synthesized from the amino acids glutamate, glycine 
and cysteine. Glutathione directly quenches ROS such as lipid peroxides, and also plays a 
major role in xenobiotic metabolism. Exposure of the liver to xenobiotic substances 
induces oxidative reactions through the upregulation of detoxification enzymes, i.e., 
cytochrome P-450 mixed-function oxidase. When an individual is exposed to high levels 
of xenobiotics, more glutathione is utilized for conjugation (a key step in the body’s 
detoxification process) making it less available to serve as an antioxidant. Research 
suggests that glutathione and vitamin C work interactively to quench free radicals and 
that they have a sparing effect upon each other (Jacob ., 1995). 
 
PLANTS AS ANTIOXIDANTS 
 In search of novel sources of antioxidants in the last years, medicinal plants have been 
extensively studied for their antioxidant activity. From ancient times, herbs have been 
used in many areas including nutrition, medicine, beverages, cosmetics, flavoring etc. The 
ingestion of fresh vegetables, fruit and tea rich in natural antioxidants has been associated 
with prevention of cancer and cardiovascular diseases (Willcox et al., 2004). The higher 
intake of plant foods correlates with lower risk of mortality from these diseases (Johnson., 
2001). Approximately 60 % of the commercially available anti-tumoral and antiinfective 
agents are of natural origin (Cragg et al., 1997).  
Many plant-derived substances, collectively termed “phytochemicals” or 
“phytonutrients” are increasingly known for their antioxidant activity. Botanicals have 
been used for treatment or prevention of various human diseases throughout history. The 
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cancer chemopreventive activities of naturally occurring phytocompounds is of great 
interest. Many indigenous herbal plants of regional interest have been used popularly as 
folk medicines in India or other Asian countries. 
Cancer chemoprevention by using antioxidant approaches has been suggested to offer 
a good potential in providing important fundamental benefits to public health and it is 
now considered by many oncologists and researchers as a key strategy for delaying, 
inhibiting, or even reversal of the process of carcinogenesis (Lie-Fen Shyur et al., 2005). 
Plants having vitamins (C, E, carotenoids, etc.), flavanoids (flavones, isoflavones, 
flavonones,anthocyanins and catechins), polyphenols (ellagic acid, gallic acid and 
tannins) possess remarkable anti oxidant activity. Anti oxidant activity is neither 
restricted to a particular part of the plant nor the specific families (Vivek  and Surendra ., 
2006). 
Besides, phenolic compounds and flavonoids are also widely distributed in plants 
which have been reported to exert multiple biological effects such as free radical 
scavenging abilities, antioxidant, anti- inflammatory, anticarcinogenic etc. As crude 
extracts of herbs and spices and other plant materials that are rich in phenolics are of 
increasing interest in the food industry because they retard oxidative degradation of lipids 
and thereby improve the quality and nutritional value of food. While, flavonoids are a 
group of polyphenolic compounds with known properties, which include inhibition of 
hydrolytic and oxidative enzymes, free radical scavenging and anti-inflammatory action. 
Natural antioxidants especially phenolics and flavonoids from tea, wine, fruits, 
vegetables and spices are already exploited commercially either as antioxidant additives 
or as nutritional supplements. Also many other plant species have been investigated in the 
search for novel antioxidants, but generally there is still a demand to find more 
information concerning the antioxidant potential of plant species as they are safe and also 
bioactive. Therefore, considerable attention in recent years has been directed towards the 
identification of plants with antioxidant ability (Vinay R P et al., 2010). 
 
 The present study aims at evaluating the chemoprotective efficacy of the Plant 
Gmelina arborea against cyclophosphamide induced toxicity, as the well known cancer 
treating drug has number of side effects especially toxicity towards hematopoetic system.   
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2. REVIEW OF LITERATURE 
Anticancer activity of cyclophosphamide 
 Yasmine S Touil et al., 2006 studied the antiangiogenic and antitumour activity of the 
combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung 
carcinoma-bearing mice. Fisetin was administered i.p. at 223 mg/kg daily for 5 days in 
week 1 (days 4 to 8 post tumour implantation), followed by 3 injections on 11th, 12th and 
14th day. Fisetin treatment led to a 67% tumour growth inhibition compared to the 
controls. Low dose cyclophosphamide was administered at 30 mg/kg on four days in 
week 1 only (days 4, 5, 7, 8), and led to a tumour growth inhibition of 66%, similar to 
fisetin treatment. When fisetin and cyclophosphamide were combined at the same dose 
schedules and levels as used above, results in dramaticall declination in tumour volumes, 
ie 92% inhibition when compared to controls on day 15. Over the two week treatment, 
only a 4.6% loss in body weight was observed showing drug combination was not toxic. 
 
 Colleoni M et al., 2001 studied the effect of low dose oral methotrexate and 
cyclophosphamide in metastatic breast cancer, its antitumour activity and correlation with 
vascular endothelial growth factor levels (VEGF). They evaluated the clinical efficacy by 
means of direct cytotoxicity on tumour cells. The continous low dose CTX and MTX is 
minimally toxic and effective in pretreated breast cancer patients and there is a drop in 
VEGF which was associated with the treatment. Combinations of therapy that inhibit 
angiogenesis plus cytotoxic therapy may be more effective than either type of therapy 
alone. 
 
Cyclophosphamide toxicity 
 
 Haubitz M (2007) carried out a study to find out the acute and long term toxicity of 
cyclophosphamide. Cyclophosphamide has been shown to increase the incidence of 
malignancies e.g. of the bladder, the haematopoetic system and the skin. There is a 1.6- to 
2.4-fold overall increase in malignancies, depending on the total CTX dose and the time 
of follow-up. For skin cancer the risk increases up to 10.4-fold, for lymphomas up to 11-
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fold and for leukaemia up to 5.7-fold. Regarding bladder carcinoma, the incidence varies 
between less than 1 %, 3 % and 5 % corresponding to a 5 to 33 fold increase. The risk 
rises with the total CTX dose administered and the follow-up, and an incidence of 16 % 
has been reported after 15 years. It is difficult to pinpoint a critical dose. Regarding 
patients with renal involvement or with alveolitis or other severe manifestations, oral 
CTX can be replaced safely by intravenous pulse administration, leading not only to a 
reduction of about 60 % in total dose but also to a marked risk reduction concerning 
leukopenia and other infections.               
 
 George B McDonald et al., 2003 examined patients with hematologic malignancy 
undergoing allogeneic transplantation following a preparative regimen of 
cyclophosphamide (CTX) plus total body irradiation to study liver toxicity after 
cyclophosphamide and total body irradiation and concluded that increased exposure to 
toxic metabolites of cyclophosphamide leads to increased liver toxicity             
 
           Tatiane Yumi Nakamura Kanno et al., 2009 evaluated the effect of different doses of 
cyclophosphamide on male mice reproductive parameters. During the study, it was 
observed a decrease in body mass and a decrease in kidneys and testicles weight in all 
animals treated with cyclophosphamide. Only those groups that received the doses 100 
and 150 mg.kg-1 of cyclophosphamide were able to fertilize their females. Abnormal 
spermatozoa were found in the doses 200, 250 mg.kg-1.  
  
Chemoprotecive effect against cyclophosphamide induced toxicity 
 In 1996 Kemp G et al studied the protective effect of Amifostine against 
cyclophosphamide-induced and cisplatin-induced toxicities without reducing the 
anticancer efficacy of these drugs: in patients with advanced ovarian cancer. Two 
hundred forty-two patients with advanced ovarian cancer were randomized to receive six 
cycles of cyclophosphamide (1,000 mg/m2) and cisplatin (100 mg/m2) with or without 
amifostine (910 mg/m2) every 3 weeks for six cycles. Pretreatment with amifostine 
before each cycle of chemotherapy resulted in a reduction of cumulative hematologic, 
neurologic and renal toxicities associated with the CTX regimen, with no reduction in 
antitumor efficacy. 
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 Renato Santos-Mello et al., 2005 studied the ability of Cysteamine or 2-
mercaptoethylamine (MEA) to protect mouse bone marrow polychromatic erythrocytes 
against the induction of micronuclei by alkylating agents such as cyclophosphamide 
(CTX) and methyl methanesulfonate (MMS). They observed that MEA administered 
intraperitoneally 30 min before or 30 min after the administration of CTX or MMS  
significantly reduced the frequency of micronucleated polychromatic erythrocytes 
(MNPCEs) induced by the alkylating agents. When Cysteamine was administered in 
combination with CTX or MMS the reduction in the frequency of MNPCEs did not reach 
levels that are statistically significant, even though it has reached the values close to 
significance. With respect to the polychromatic erythrocyte/normochromatic erythrocyte 
(PCE/NCE) ratio, they observed that MEA did not provide significant protection against 
the bone marrow toxicity induced by CTX. 
 
 Adel RA Abd-Allah et al., 2004 reported the effect of taurine, on cyclophosphamide 
(CTX) induced urinary bladder toxicity was investigated by administration of a single 
dose of CTX (150 mg/kg, i.p.). The results of their study suggest that CTX induced 
cystitis is related to oxidative stress and ROS formation owing to depletion of GSH 
and/or inflammation. Taurine, which was useful for the amelioration of the toxicity of 
other models of oxidative stress including hepatitis, liver ailments and the complications 
of diabetes can also protect the structure and function of the urinary bladder against CTX-
induced oxidative stress. 
  
 Praveen Kumar et al., 1995 reported that oral administration of Septilin protects mice 
from cyclophosphamide-induced leukopenia. Total leukocyte counts in Septilin treated 
animals on day 12 were 2400 cells/mm
3 
which was significantly higher (p<0.005) 
compared to controls (700 cells/mm
3
) and reached the base line value on 16th day (12,000 
cells/mm
3
). The bone marrow cellularity(BMC) was also significantly higher compared to 
controls and there was no change in the level of hemoglobin in Septilin treated animals. 
Septilin treatment reduced the mortality in mice and prevented the loss of body weight 
treated with cyclophosphamide. This indicates the usefulness of Septilin during 
chemotherapy-induced leukopenia. 
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Plants as chemoprotectors 
 
 Ali Shalizar Jalali et al., 2011 conducted a study to assess whether Crataegus 
monogyna fruits aqueous extract with anti-oxidant properties could serve as a protective 
agent against reproductive toxicity during cyclophosphamide treatment in a rat model. 
The CTX-treated group showed significant decreases in the body and organ weights and 
spermatogenic activities as well as many histological alterations. CTX treatment also 
caused a significant decrease in sperm count and motility with an increase in abnormal 
and dead sperms. Significant decrease in serum levels of testosterone and increased serum 
concentrations of FSH, LH, LDH, CPK and SGOT were also observed in CTX-treated 
rats. Notably, Crataegus coadministration caused a partial recovery in above parameters. 
These findings indicate that Crataegus monogyna fruit extract might be partially 
protective against CTX-induced reproductive toxicity. 
 
 Kamel Rouissi et al., 2012 investigated the effects of pre-treatment with Aloe vera 
plant extract (AVE) on the urotoxicity induced by acute doses of Cyclophosphamide and 
Buthionine Sulfoximine using a Swiss albino mice model. The toxicity modulations were 
evaluated by measuring hydrogen peroxide production (H2O2), lipid peroxidation (LPO) 
and antioxidants in the urinary bladder of the animals. The findings revealed that Aloe 
vera plant extract induced remarkable protective effects in terms of both LPO and 
enzymatic antioxidant activities. 
 There are number of studies have been carried out using plants as chemoprotecting 
agents against cyclophosphamide induced toxicity. The immunomodulatory and 
chemoprotective effect of methanolic extract of Acacia nilotica (Ahmad S et al., 2012) 
and Moringa oleifera Lam (Anamika Gupta et al., 2010) was reported. Chemoprotective 
effect of garlic extract towards cyclophosphamide toxicity in mice was studied by 
Unnikrishnan M C et al., 1990. In 2012, Vinod Prabhu V and Guruvayoorappan C 
evaluated the immunostimulant activity and chemoprotective effect of mangrove 
Rhizophora apiculata against cyclophosphamide induced toxicity in BALB/c mice. 
Amelioration of cyclophosphamide-induced hepatotoxicity by the root extract of 
Decalepis hamiltonii in mice was studied by Mahsa Zarei and Shivanandappa T., 2013. 
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The effect of Unani Formulation (Jawarish amla sada) on Cyclophosphamide induced 
Toxicity in Tumour Bearing Mice was evaluated by Firoz Ahmad et al., 2012. 
 Yukmijihwang-tang (YJT) is a multi-herbal medicinal formula that has been used in 
traditional Asian medicine to treat male reproductive problems. Oh M S et al., 2007 
investigated the effects of YJT on Cyclophosphamide (CTX) induced reproductive 
toxicities in rat testes. The results of their study suggested that YJT has a protective effect 
against CTX-induced reproductive toxicities by inhibiting the increases in lipid 
peroxidation and enhancing cAMP-responsive element modulator (CREM) expression. 
 Haque R et al., 2003 investigated the modulatory effects of walnut extract on the 
toxicity of an anticancer drug, cyclophosphamide (CTX) with special reference to 
protection against disruption of drug metabolizing and antioxidant enzymes. Plant 
extract+CTX group animals showed restoration in the level of cytochrome P450 (CYP) 
content and in the activities of glutathione S-transferase (GST), glutathione peroxidase 
(GPx) and catalase (CAT) in both liver and kidneys. 
 
Pharmacological activities of the plant Gmelina arborea. 
 
 Rezvanfar M et al., 2008 reported that Satureja khuzestanica essential oil (SKEO) 
protects reproductive system of rats from toxicity of cyclophosphamide through its 
antioxidant potential and androgenic activity Gmelina arborea. 
 Anuj M Pandey & Yogesh Kulkarni (2010) studied  the antioxidant activity of bark of 
Gmelina arborea by various In vitro techniques. Phytochemical studies were performed 
on the extracts ie, Methanolic extract (ME) and Aqueous extract (AE). Assays performed 
were Free radical scavenging assay, Reducing power assay and Nitric oxide screening 
activity. The study revealed that the plant Gmelina arborea possesses antioxidant activity. 
The antioxidant activities of Gmelina arborea were attributed to the presence of phenolic 
compounds. 
 
 Vijay T et al., 2011 investigated the potential protective effect of Gmelina arborea 
(GA) against Doxorubicin (DOX) induced cardiotoxicity in rats. GA protected against 
DOX-induced increased levels of marker enzymes. It significantly inhibited DOX-
Evaluation of the chemoprotective activity of 70% methanolic extract of Gmelina arborea stem bark against 
cyclophosphamide induced toxicity 
 
RVS College of Pharmaceutical Sciences, Dept. Of Pharmacology, Sulur, Coimbatore.  Page 37 
 
provoked glutathione (GSH) depletion in cardiac tissues. The declination of cardiac 
activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-
Px) and glutathione reductase (GR) were significantly mitigated. Pretreatment of GA 
significantly guarded against DOX-induced rise of serum lactate dehydrogenase (LDH). 
GA alleviated histopathological changes in rats’ hearts treated with DOX. In conclusion, 
GA protects against DOX-induced cardiotoxicity in rats. The results can be attributed to 
GA’s antioxidant activity. 
 
 Syamsul Falah et al., 2008 extracted the bark meal of Gmelina arborea Roxb. with 
acetone and methanol. Fractionation of the acetone extract with n-hexane, ethoxy ethane, 
ethyl acetate and subsequent chromatographic separation of the fractions led to the 
isolation of 4 compounds. The diethyl ether-soluble fraction yielded tyrosol [2-(4-
hydroxyphenyl)ethanol], 8-5′ neolignan and (+)-balanophonin with opposite optical 
rotation to known gmelinol, a known lignin and (−)-balanophonin. The ethyl acetate-
soluble fraction afforded a new phenylethanoid glycoside to the best of our knowledge, 
which was identified as (−)-p-hydroxyphenylethyl[5′″-O- (3,4-dimethoxycinnamoyl)-b-
D-apiofuranosyl(1′″ → 6′)]-b-D-glucopyranoside. From the methanol extract, two known 
compounds, 2,6-dimethoxy-p-benzoquinone  and 3,4,5-trimethoxyphenol , were isolated 
and identified. The 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging assay 
of the identified compounds indicated that 3,4,5-trimethoxyphenol  exhibited moderate 
activity. 
 
 A M El-Mahmood et al., 2010 monitored antimicrobial activity using the agar 
diffusion method. He reported that the crude extracts of the leave and stem bark of the 
plant G. arborea inhibited the growth of such recalcitrant pathogenic Klebsiella 
pneumonieae, Escherichia coli, Shigella dysenteriea, Proteus mirabilis, and Salmonella 
typhi. 
  
 Ambujakshi H R et al., 2009 studied the effect of anthelmentic activity of alcoholic 
and aqueous leaves extracts of Gmelina arborea Roxb. The plant extract exhibited 
anthelmentic activity in dose dependent manner giving shortest time of paralysis and 
death compared to piperazine citrate especially with 100mg/ml concentration for 
Pheretima posthuma and Ascardia galii worms by increasing chloride ion conduction of 
Evaluation of the chemoprotective activity of 70% methanolic extract of Gmelina arborea stem bark against 
cyclophosphamide induced toxicity 
 
RVS College of Pharmaceutical Sciences, Dept. Of Pharmacology, Sulur, Coimbatore.  Page 38 
 
worm muscle membrane produces hyperpolarisation and reduces excitability that leads to 
muscle to relaxation and flaccid paralysis. 
 
 Saravani P et al., 2011 reported that, Gmelina arborea methanolic extract have 
significant diuretic activity on albino rats. There was an increase in the ratio of 
concentration of excreted sodium and potassium ions after methanolic extract of GA 
treatment. This indicates that the GA extract increases sodium excretion to larger extent 
than potassium which leads to hyperkalaemic side effect. 
 
 Pattanayak P et al., 2011 conducted a study to find out the effect of antidiabetic 
activity of ethanolic extract of G.arborea bark at dose of 420 mg.kg-1 and 
chlorpropamide at dose of 200 mg.kg-1 was found to reduce the increase of blood sugar 
in sreptozotocin (50 mg.kg-1) induced diabetes due to the increased blood GSH levels 
reinforcing the role of GSH as free radical scavenger and in the repair of free radical 
caused biological damage. 
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3. AIM 
 In recent years much attention has been showered on the therapeutic impact of plant 
derived drugs and phytochemicals on various infectious and non infectious diseases. 
Compared to its alternative forms, herbal medicine has high efficacy, is economically 
cheaper and imposes lesser side effects on the subject. The selection of this plant Gmelina 
arborea was made on the basis of its: 
 High therapeutic value 
 Wide use in Ayurvedic System of Medicine 
 Degree of research work which is not yet performed 
 Very less pharmacological studies have been carried out on the barks of Gmelina 
arborea. Hence, we have decided to submit the project on Gmelina arborea emphasizing 
on the chemoprotective activity against cylcophosphamide induced toxicity. 
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4. SCHEME OF THE PROPOSED WORK 
 
Selection of Gmelina arborea stem bark 
↓ 
Preparation of  Gmelina arborea stem bark 70% methanolic extract using soxhlet extraction 
apparatus 
↓ 
Evaluation of chemoprotective activity against cyclophosphamide indued activity 
                                                                                                                                                                               
  
Serum activity         Tissue activity         Blood parameters     Bone marrow     Histopathology              
                                                                                                     cellularity  
          
                ALT                           GPX                           WBC 
                AST                            GSH                            Hb 
                ALP                            SOD 
                Urea                            Lipid peroxidtion 
                Creatininne 
                Total protein 
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5. PLANT  PROFILE 
                                                     
 
Fig 4: Photograph of Gmelina arborea plant (Taken from Amala Ayurvedic garden,    
Amala Institute of Medical Sciences, Thrissur). 
 
TAXONOMICAL CLASSIFICATION        
Table: 2 – Taxonomical classification of G.arborea 
Kigdom Plantae 
Division Magnoliophyta 
Class Magnoliopsida 
Sub class Asteridae 
Order Lamiales 
Family Verbenaceae 
Genus Gmelina 
Species G. arborea 
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VERNACULAR NAMES 
Table : 3 – Vernacular names of G.arborea 
Assamese Gomari 
Bengali  Gamari, Gambar 
Hindi Gamhar, Khamara. 
Kannada  Kooli mara, Kumbuda, Shivane mara 
Malayalam Kumbil, Kumbulu 
Marathi Shivan, Siwan 
Sanskrit Gambhari, Sindhuparni 
Tamil Kumla, Kumalamaram 
Telugu Gumartek, Gummadi, Summadi 
 
BOTANICAL DESCRIPTION 
 Gmelina arborea is a large deciduous tree, which grows on different localities and 
mainly prefers the moist fertile valleys with 75–450 cm rainfall. It does not thrive on un-
drained soils and remains stunted on sandy, dry or poor soils; drought also reduces it to a 
shrubby form. 
 The Gmelina arborea tree attains height up to 30 m and its wood is pale yellow to 
cream coloured or plukish-buff when fresh, turning yellowish brown on exposure and is 
soft to moderately hard, light to moderately heavy, lustrous when fresh, usually straight to 
irregular or rarely wavy grained and medium course textured. 
Leaves are large, tomentose underneath, cordate-ovate, acuminate. 
 Flowering takes place during February to April when the tree is more or less leafless 
whereas fruiting starts from May onwards up to June.  
 The fruit is up to 2.5 cm long, drupe, smooth, dark green, turning yellow when ripe 
and has a fruity smell. 
DISTRIBUTION 
 In India, Gmelina arborea occurs extensively from the Ravi eastwards in the sub-
Himalayan tracts, and it is common throughout Assam and the adjoining areas of 
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northern West Bengal, Odisha and also in southern Bihar, periodically found in western 
and southern India and planted elsewhere on a large scale. Gamhar most commonly seen 
in West Bengal forests (mixed forests). It also occurs naturally in Thailand, Myanmar, 
Laos, Vietnam, Cambodia and in southern provinces of China. 
MAJOR CHEMICAL CONSTITUENTS  
 Lignans such as 4-hydroxysesamin, 6“- bromo–isoarboreol, 4,8-dihydroxysesamin, 
1,4-dihydroxysesamin (gummadiol), 2 piperonyl-3-hydroxymethyl-4-(α-hydroxy-3,4-
methylenedioxybenzyl)-4-hydroxytetrahydrofuran and the 4-O-glucoside of 4-
epigummadiol can be isolated from the heartwood of Gmelina arborea (A S R 
Anjaneyulu et al., 1977). The parent compounds are arboreol or gmelanone ( A S R 
Anjaneyulu et al., 1975).  
 Presence of Umbelliferone 7-apiosylglucoside in the root is reported (P  
Satyanarayana et al., 1985). Other constituents present in plant are β-sitosterol, ceryl 
alcohol, gmelinol; butyric acid & tartaric acids; apigenin, premnazole, arborone, 
isoarboreol, cutytyl ferulate, epieudesmin, gmelanore, gmelafuran, gummadiol, 
saponifiable fraction, apiosyl-skimmin, octacosanol etc. 
TRADITIONAL USES (Kaswala Rohit et al., 2012) 
• The bark of Gmelina arborea are stomachic, galactogogue, laxative and 
antihelmenthic, improve appetite, useful in abdominal pains, hallucination, piles, 
fever, burning sensations, urinary discharge and Tridosha. For the treatment of snake 
bite and scorpion sting GA is also recommended with other drugs. 
• Leaf paste is applied to relieve headache and juice can be used as wash for ulcers. 
Gamhar leaves, bark skin of Saimali and Apamarga roots are mashed with cow’s milk 
and are given orally to treat hyperacidity. The leaves juice, sugar and milk are 
recommended in inflammatory condition of urinary bladder and dysuria. 
• Flowers are sweet, cooling, acrid, bitter and astringent which is useful in leprosy and 
blood diseases. 
• Fruit is acrid, sour, bitter, sweet, cooling, diueretic, tonic, promote growth of hairs, 
aphrodisiac, useful in Vata, anaemia, thirst, ulcers, leprosy and vaginal discharge. It is 
also recommended in raktapitta, excessive thirst, habitual abortion and sexual debility 
in males. In heart disease of vata imbalance the ripened fruit is valuable. 
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• The roots are described in the ayurvedic tests as mild laxatives which treats flatulence, 
increase appetite, lactation and menstrual irregularities. The cold infusion of gamhar, 
ustra and candana works well with sugar to alleviate the thirst. It is also usefull in 
piles, burning sensation, fever and ‘Tridosha’. 
IMPORTANT PREPARATIONS 
Dasamularishta, Sriparni taila; Draksadi Kvatha, Kasmaryadi panaka, Kasmarya 
rasayana, Kasmarya taila. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluation of the chemoprotective activity of 70% methanolic extract of Gmelina arborea stem bark against 
cyclophosphamide induced toxicity 
 
RVS College of Pharmaceutical Sciences, Dept. Of Pharmacology, Sulur, Coimbatore.  Page 45 
 
6. MATERIALS & METHODS 
1. PLANT MATERIAL :- 
Binomial name  : Gmelina arborea Roxb. 
Family   : Verbenaceae 
Common name  : Gamhar 
Habit   : Tree 
Part used   : Stem bark 
 
Collection:-  The stem bark of Gmelina arborea Roxb. was collected from Amala 
Ayurvedic garden, Amala Nagar, Thrissur.  
2. ANIMALS :- 
Male Balb/C mice were purchased from the Small Animal Breeding Station, 
Agricultural University, Mannuthy, Kerala, India. The animals were maintained under 
standardized environmental conditions (22-280C, 60-70% relative humidity, 12hr 
dark/light cycle) and fed with standard rat feed (Lipton India) and water ad libitum. All 
animal experiments were conducted during the present study got prior permission from 
Institutional Animal Ethics Committee (IAEC approved) and followed the guidelines of 
IAEC(No:- 149/1999/CPCSEA). 
3. REAGENTS AND CHEMICALS :- 
All chemicals used were of analytical quality. 
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METHODS                                                                                             
I. PLANT EXTRACT PREPARATION:- 
The stem bark was chipped from the collected stems and was dried in a hot air 
oven at a temperature of 45oC. This was then ground to fine powder and extracted with 
70% methanol as the solvent, using a Soxhlet apparatus. The extract was filtered and 
evaporated to dryness. The dried extract was re-dissolved in distilled water and used for 
further studies. 
II. ANIMAL GROUPING AND TREATMENT REGIME:- 
The animals (with body weights ranging from 25 to 30 gm) were divided into 4 
groups of 6 animals each:-   
Group I: Normal – Untreated. 
Group II: Control – Cyclophosphamide (20 mg/kg b.wt). 
Group IV: GALC – Gmelina arborea extract low concentration (250 mg/kg b.wt) and 
Cyclophosphamide (20 mg/kg b.wt). 
 Group V: GAHC - Gmelina arborea extract high concentration (500 mg/kg b.wt) and 
Cyclophosphamide (20 mg/kg b.wt). 
 
The GALC and GAHC groups were orally treated with the extract at doses of 250 
mg/kg body weight and 500 mg/kg body weight respectively, for a continuous time 
period of 20 days, at an administration volume of 0.1 ml for each animal. Within this 
period, all groups, except normal also received oral administration of cyclophosphamide 
at a dose of 20 mg/kg body weight, starting from the sixth day upto the fifteenth. 
 For determining the bone marrow cellularity on the 7th and 14th day, 4 animals each  
were separately stocked for control, GALC and GAHC groups with the above mentioned 
treatment regime till their sacrifice. On the initial day of the study, 4 animals separately 
stocked for the purpose were sacrificed from the normal group. 
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III. DETERMINATION OF TOTAL WBC COUNT AND HAEMOGLOBIN 
LEVEL:- 
During the course of the study, the haematological parameters of the animals were 
tracked on every 5th day. For this, blood was collected from the caudal vein into 
heparinised tubes and total WBC count and haemoglobin level were checked. 
A. Determination of total count: 
Principle: 
 The whole blood was diluted using a diluent which haemolyses red cells, leaving all 
the nucleated cells intact. The number of white cells in a known volume and known 
dilution were counted using a counting chamber.  
Procedure: 
 0.02 ml of blood was added to 0.38 ml of diluting fluid and mixed well. The diluted 
blood was charged into a Neubauer counting chamber. After 3-4 min, the total number of 
white blood cells in the four large corner square chambers was counted.  
Calculation: 
 Total WBC = (Number of cells counted x 50) / mm3    
 
B. Determination of haemoglobin (Hb) content: 
 Cyanmethaemoglobin method (Kit manufactured by Agappe Diagnostics). 
Principle: 
 Haemoglobin was treated with a reagent containing potassium ferricyanide, potassium 
cyanide and potassium dihydrogen phosphate. The ferricyanide forms methaemoglobin, 
which is converted to cyanmethaemoglobin by cyanide. The intensity of colour formed is 
measured at 546 nm against blank. The optical density is directly proportional to the 
amount of haemoglobin present in blood.  
Procedure: 
 0.02 ml of fresh whole blood was mixed with 5 ml of the cyanmeth reagent. The 
optical density was measured at 546 nm against blank after 5 min incubation at room 
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temperature. The OD of standard solution corresponding to 60 mg/dl haemoglobin at 546 
nm was also read against reagent blank. 
Calculation: 
 Haemoglobin (g/dL) = (OD of treated x 60 x 0.251) / OD of standard 
IV. ESTIMATION OF BODY WEIGHT: 
 The body weights of all the animals were measured, starting from the first day, and 
repeated every fifth day, until sacrifice.  
On the 21st day of the study, the animals were sacrificed and the blood and tissue 
parameters, relative organ weights as well as the bone marrow cellularity were checked. 
V. DETERMINATION OF RELATIVE ORGAN WEIGHTS:- 
 After sacrifice, the liver, kidney, spleen, heart and brain were excised and weighed. 
The percentage weight of each organ, relative to the total body weight was determined.  
VI. DETERMINATION OF BONE MARROW CELLULARITY:-  
Bone marrow cells from both femurs were flushed out with phosphate buffered 
saline. The number of bone marrow cells were determined using a haemocytometer and 
expressed as total live cells (×106)/femur. 
VII. EVALUATION OF BIOCHEMICAL PARAMETERS:- 
 
1. SERUM PARAMETERS: 
 
A. Estimation of Aspartate aminotransferase (AST)/ SGOT:-  
2,4-DNPH  (Reitman and Frankel Method)  
Kit manufactured by Span diagnostics Ltd. (Cogent) was used for this estimation. 
 Principle:  
   Aspartate aminotransferase, also known as Glutamate Oxaloacetate Transaminase 
(GOT) catalyses the transamination of L-aspartate and α keto glutarate to form 
oxaloacetate and L- glutamate. Oxaloacetate formed is coupled with 2,4- Dinitrophenyl 
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hydrazine to form hydrazone, a brown coloured complex in alkaline medium which can 
be colorimetrically measured. 
Reagents:  
   Buffered aspartate (pH 7.4); 2,4- DNPH reagent;  4N sodium hydroxide;  working 
pyruvate standard ;  solution I (prepared by diluting 1 ml of reagent 3 to 10 ml with 
purified water). 
Procedure:  
  The reaction systems used for this study included blank, standard, test (for each 
serum sample) and control (for each serum sample). 0.25 ml of buffered aspartate was 
added into all the test tubes. This was followed by the addition of 0.05 ml of serum into 
the test group tubes and 0.05 ml of working pyruvate standard into the standard tubes. 
After proper mixing, all the tubes were kept for incubation at 37oC for 60 minutes, after 
which 0.25 ml each of 2,4- DNPH reagent was added into all the tubes. Then, 0.05 ml of 
distilled water and 0.05 ml of each serum sample was added to the blank and the serum 
control tubes respectively. The mixture was allowed to stand at room temperature for 20 
minutes. After incubation, 2.5 ml of solution I was added to all test tubes. Mixed properly 
and optical density was read against purified water in a spectrophotometer at 505 nm 
within 15 minutes. 
The enzyme activity was calculated as:-  
AST (GOT) activity in IU/L) =  
[(Absorbance of test - Absorbance of control)/ (Absorbance of standard - Absorbance of 
blank)] x concentration of the standard                                               
 
B. Estimation of Alanine Aminotransferase (ALT)/ SGPT:-  
2,4-DNPH  (Reitman and Frankel Method)  
Kit manufactured by Span diagnostics Ltd.(Cogent) was used for this estimation. 
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Principle: 
  Alanine aminotransferase also known as Glutathione Peroxidase (GPT) catalyses the 
transamination of L-alanine and α keto glutarate to form pyruvate and L- Glutamate. 
Pyruvate so formed is coupled with 2,4 – Dinitrophenyl hydrazine to form a 
corresponding hydrazone, a brown coloured complex in alkaline medium which can be 
measured colorimetrically. 
Reagents: 
 Buffered alanine (pH 7.4), 2,4–DNPH, 4N sodium hydroxide, working pyruvate 
standard, solution I (prepared by diluting 1 ml of reagent 3 to 10 ml with purified water). 
 Procedure:  
  The reaction systems used for this study included blank, standard, test (for each 
serum sample) and control (for each serum sample). 0.25 ml of buffered alanine was 
added into all the test tubes. This was followed by the addition of 0.05 ml of serum into 
the test group tubes and 0.05 ml of working pyruvate standard into the standard tubes. 
After proper mixing, all the tubes were kept for incubation at 37oC for 60 minutes, after 
which 0.25 ml each of 2,4- DNPH reagent was added into all the tubes. Then, 0.05 ml of 
distilled water and 0.05 ml of each serum sample was added to the blank and the serum 
control tubes respectively. The mixture was allowed to stand at room temperature for 20 
minutes. After incubation, 2.5 ml of solution I was added to all test tubes. Mixed properly 
and optical density was read against purified water in a spectrophotometer at 505 nm 
within 15 minutes. 
The enzyme activity was calculated as:-  
ALT (GPT) activity in IU/L) =  
[(Absorbance of test - Absorbance of control) / (Absorbance of standard - Absorbance of 
blank)] x concentration of the standard                                               
 
C. Estimation of Alkaline phosphatase:- 
Kind & King’s method 
Kit manufactured by Span diagnostics Ltd.(Cogent) was used for this estimation. 
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Principle:                                                                                                                  
 Alkaline phoshatase from serum converts phenyl phosphate to inorganic phosphate 
and phenol at pH 10.0. Phenol so formed reacts in alkaline medium with 4-
aminoantipyrine in presence of the oxidising agent potassium ferricyanide and forms an 
orange-red coloured complex, which can be measured spectrometrically. The color 
intensity is proportional to the enzyme activity. 
Reagents: 
Buffered substrate 
Chromogen Reagent 
Phenol Standard, 10 mg% 
Procedure: 
The working solution was prepared by reconstituting one vial of buffered substrate with 
2.2 ml of water. 0.5ml of working buffered substrate and 1.5 ml of purified water was 
dispensed to blank, standard, control and test. Mixed well and incubated at 370C for 3 
minutes. 0.05 ml each of serum and phenol standard were added to test and standard test 
tubes respectively. Mixed well and incubated for 15 minutes at 370C. Thereafter, 1 ml of 
chromogen reagent was added to all the test tubes. Then, added 0.05 ml of serum to 
control. Mixed well after addition of each reagent and the O.D of blank, standard, control 
and test were read against purified water at 510nm. 
Calculation: 
Serum alkaline phosphatase activity in KA units =  
          [(O.D. Test-O.D. Control) / (O.D. Standard- O.D. Blank)] x 10 
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D. Estimation of Creatinine:-  
Jaffe’s Kinetic method  
Kit manufactured by Asritha Diatech India (Euro) was used for this estimation. 
Principle: 
      Creatinine is the catabolic product of creatinine phosphate which is used by the 
skeletal    muscle. The daily production depends upon the muscular mass and it is 
excreted out of the body through kidney. Creatinine present in the sample generates a 
coloured complex upon reacting with sodium picrate. 
creatinine + sodium picrate → creatinine-picrate complex 
Reagents: 
R1- Picric acid reagent 
R2- Alkaline buffer 
Creatinine standard -  2 mg/ dl. 
Procedure: 
Working reagent (WR) was prepared by mixing equal volumes of R1 and R2. The 
reaction systems consisted of standard and test solutions. 1 ml of WR was dispensed to all 
the tubes, followed by the addition of 0.05 ml of creatinine standard and 0.05 ml of serum 
into the standard and test sample tubes respectively. Mixed well and read the absorbance 
of standard and test against distilled water at 520 nm after 30 sec (A0) and 90 sec ( A1) 
         ∆A for standard (S) and Test (T) was determined as:- 
         ∆As = AS1- AS0 
              ∆AT = ATI-ATO 
Serum creatinine (mg/dl) = (∆AT/∆As) x 2 
E. Estimation of Serum Urea:- 
  Estimation was done by Berthelot Enzymatic method for the determination of urea in 
serum. 
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 Principle: 
 Urea is converted quantitatively by urease into ammonia and carbon di oxide. The 
ammonium ions react with hypochlorite and salicylate to give a green coloured complex. 
The colour is enhanced by sodium nitroprusside. The intensity of color s directly related 
to urea concentration and is measuresd photometrically at 578 nm. 
Reagents: 
  R1- urease and sodium salicylate ; R 2- alkaline hypochlorite solution ; standard 40 
mg/dl 
Procedure: 
 Working reagent was prepared by the addition of 25 ml of distilled water to R1. From 
this 1ml of solution was pip petted out into all the test tubes. 0.01 ml of distilled water 
was added into the blank test tube followed by 0.01 ml of standard into the standard tube 
and 0.01 ml of serum into the test tubes. Mixed well and incubated for 5 minutes at 37c 
followed by addition of 1 ml of R2 into all the test tubes. Mixed well and incubated for 5 
minutes at 37c. At the end of incubation absorbance of standard and test was measured 
against blank at 578nm. 
   Urea mg/dl = At /As × 40 
F. Estimation of Serum Total Protein:-  
Biuret method 
Kit manufactured by Asritha Diatech India (Euro) was used for this estimation. 
Principle: 
Protein + Cu++ → Blue- violet coloured complex 
The intensity of the colour formed is directly proportional to the amount of total proteins 
present in the sample. 
Reagents: 
Biuret reagent, Protein standard (6g/dl) 
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Procedure:  
 1 ml Biuret reagent was added into all the test tubes followed by 0.01 ml of total 
protein standard into the standard tube and 0.01 ml of serum into the test groups. Mixed 
well and incubated at 37˚c for 5 minutes.Measured the absorbance of standard and test 
sample against blank at 555nm within 60 minutes. 
Calculation: 
Total protein (g/dl) = (O.D. test / O.D. std.) x 6 g/dl 
 
2. TISSUE ANTI-OXIDANT PARAMETERS:- 
Preparation of Tissue Homogenates (Liver & Kidney):-  
On 21st day, animals were sacrificed. Liver and kidney were excised and rinsed 
thoroughly in ice cold saline to remove the blood. They were gently blotted between the 
folds of thoroughly in ice-cold saline to remove any blood traces. They were then gently 
blotted between the folds of a filter paper and weighed in an analytical balance. 25% of 
homogenate was prepared in 0.05M phosphate buffer (pH 7) using a polytron 
homogenizer at 4˚C. A part of this homogenate was used for the determination of total 
protein & lipid peroxidation (LPO). Rest of the homogenate was centrifuged at 10,000 
rpm for 30 minutes in a cooling centrifuge for removing the cell debris, unbroken cells, 
nuclei, erythrocytes and mitochondria. The supernatant was used for the estimation of 
superoxide dismutase (SOD), total protein, glutathione peroxidase (GPx) and glutathione 
(GSH). 
A. Estimation of Tissue Superoxide Dismutase (SOD) Activity:-  
Principle: 
The assay is based on the ability of enzyme to inhibit the reduction of nitro blue 
tetrazolium (NBT) by Superoxide, which is generated by the reaction of photo reduced 
riboflavin with oxygen. 
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Reagents: 
M/15 Phosphate buffer, pH 7.8, EDTA (0.1M) containing 1.5 mg of sodium 
cyanide per 100ml, riboflavin (0.12mM), stored cold in a dark bottle and NBT (1.5mM) 
stored cold. 
 
Procedure: 
              For each sample to be assayed, the amount of enzyme added to the medium was 
kept below 1 unit of enzyme activity. Incubation medium contained 0.1ml of tissue 
sample, 0.2ml EDTA/NACN, 0.1ml NBT, and 0.05ml riboflavin and phosphate buffer to 
give a total volume of 3ml. The tube without animal sample was kept as control. 
Riboflavin was added after the tubes were brought to room temperature. Then the tubes 
were placed in a bright box where they received uniform illumination for 15 minutes. The 
optical densities were measured at 560nm. One unit of enzyme activity is defined as 
amount of enzyme giving 50% inhibition of the reduction of NBT and expressed as 
units/mg. protein. 
 
B. Estimation of Glutathione (GSH):-  
Principle: 
GSH is measured by its reaction with DTNB to give a yellow colored complex 
with maximum absorption at 412nm.  
Reagents: 
25% TCA, 5% TCA, 0.2M GSH buffer (pH 8.0), 0.6 mM 5, 5’-dithiobis 2- 
nitrobenzoic acid (DTNB). 
Procedure: 
To 0.1 ml of homogenate 125μl of 25% TCA was added to precipitate proteins. 
The tubes were cooled by keeping on ice bags for 5 minutes and the mixture was further 
diluted with 0.6 ml. of 5% TCA; centrifuged for 10 minutes and 0.1 ml of resultant 
supernatant was taken for GSH estimation. The volume of the aliquot was made up to 1 
ml with 233μl of 0.2M phosphate buffer (pH 8.0) and 667 μl of freshly prepared 0.6mM 
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DTNB The intensity of yellow colour formed by DTNB addition was read at 412 nm with 
distilled water as reference. Standard curve of GSH was prepared using concentrations 
varying from 5-100 nmol in 5% TCA for each assay. Value was expressed as nmol / mg 
protein. 
 
C. Estimation of Glutathione Peroxidase (GPx) Activity: 
 
Principle: 
Glutathione peroxidase degrades H2O2 in presence of glutathione (GSH) thereby 
depleting it. GSH remaining is measured using DTNB, which gives a coloured complex. 
Reagents: 
1M Phosphate buffer (pH 7.0), 0.2 mM GSH , 25mM Sodium azide, 1.2 mM 
H2O2, 0.4 M Na2HPO4  and -1mM 5, 5’-dithiobis (2-nitrobenzoic acid) (DTNB). 
Procedure: 
The reaction mixture containing 0.1 ml each of tissue sample, GSH, NaN3 and 
H2O2 was made up to a total volume of 2.5 ml using phosphate buffer and was incubated 
at 37°C for 6 minutes. After addition of 2 ml. of 1.67 % HPO3, this mixture was 
centrifuged at 800×g for 15 minutes. 667μl of the supernatant was added to a mixture of 
1ml of Na2HPO4 and DTNB. After 10 minutes of incubation at 37°C, the absorbance of 
the reaction mixture was measured at 412 nm, with distilled water as reference. The 
enzyme activity was expressed as units/mg protein. 
 
D. Estimation of Tissue Lipid Peroxidation 
Principle: 
Malondialdehyde (MDA) produced during peroxidation can react with 
thiobarbituric acid (TBA) reagent to form a pink coloured product which has an 
absorption maximum at 532nm. The assay is calibrated with 1,1,3,3, 
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tetramethoxypropane, which on hydrolysis produces malondialdehyde. The results are 
expressed in terms of the amount of malondialdehyde produced during the reaction. 
Reagents: 
150 mM KCl, 0.3 mM ascorbic acid, 0.8mM ferrous ammonium sulphate, 0.2 M 
tris buffer (pH 7.0), 0.8% TBA, 8.1% SDS  and 20% acetic acid (pH 3.5). 
Procedure: 
0.1ml. of the tissue sample (25%) in Tris buffer (pH 7.0) was added to a reaction 
mixture containing KCl (0.1 ml.), ascorbic acid (0.1ml.), ferrous ammonium sulphate (0.1 
ml) and tris buffer (0.1 ml.) mixed into a final volume of 0.5 ml. The reaction mixture 
was incubated for 1hr at 37°C. The amount of MDA formed was expressed as nmol/mg. 
protein. 
VII. HISTOPATHOLOGY:- 
A portion of small intestine belonging to one animal in each group was preserved 
in 10% formaldehyde solution for histopathological studies. Hematoxylin and eosin were 
used for staining; later, the histopathological slides were photographed. 
VIII. STATISTICAL ANALYSIS:-  
The experimental results are presented as Mean ± SD for 5 animals in each group. 
Statistical evaluation of the data was done by one way ANOVA followed by Dunnet’s t-
test. Results were considered statistically significant when p<0.05.  
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7. RESULTS 
 
1.  PLANT EXTRACT PREPARATION:- 
  
   The stem bark was chipped from the collected stems and was dried in a hot air oven 
at a temperature of 45oC. This was then ground to fine powder and extracted with 70% 
methanol as the solvent, using a Soxhlet apparatus. The extract was filtered and 
evaporated to dryness. The dried extract was re-dissolved in distilled water and used for 
further studies. 
Table: 4 - Characteristics of Gmelina arborea stem bark extract. 
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Table:  15 -Effect of Gmelina arborea on all serum parameters 
 
 
SERUM 
PARAMETERS 
 
 
NORMAL 
 
 
CONTROL 
 
 
GALC 
 
 
GAHC 
 
AST/ SGOT 
( IU/L) 
 
 
108.234±6.186 
 
 
129.165±8.367a 
 
 
121.386±6.382 
 
 
115.32±7.82c 
 
ALT/ SGPT 
( IU/L) 
 
 
42.975± 3.465 
 
 
82.2±8.833a 
 
 
72.384±7.212d 
 
 
55.54±5.638c 
 
ALP 
(KA) 
 
 
60.217 ± 4.739 
 
 
84.963 ± 6.629a
 
 
76.297 ± 5.729d 
 
 
65.83 ± 5.827c 
 
CREATININE 
(mg/dl) 
 
 
0.666 ± 0.028 
 
 
1.25±  0.061a 
 
 
1.083 ± 0.026c 
 
 
1 ± 0.031c 
 
UREA 
(mg/dl) 
 
 
17.871 ± 2.268 
 
 
27.335 ± 3.205a
 
 
20.087±3.432d 
 
 
18.457±3.293c 
 
 Values are expressed as mean ± SD for 6 animals; a :- p<0.01 and b :- p<0.05 compared 
to normal ; c:- p<0.01 and d:- p<0.05 compared to control. 
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Table :24  - Effect of Gmelina arborea  on tissue antioxidant parameters 
TISSUE 
ANTIOXIDANT 
PARAMETERS 
 
 
NORMAL 
 
 
CONTROL 
 
 
GALC 
 
 
GAHC 
 
SOD 
(U/mg 
protein) 
 
LIVER 
  
0.679 ± 0.078 
   
 0.382± 0.039a 
    
0.509±0.051c 
  
0.58±0.046c 
 
KIDNEY 
  
0.805 ± 0.093 
  
0.577 ±0.087a 
 
  0.68 ±.01 
 
0.72  ±0.096d 
 
GSH 
(nmol/mg 
protein) 
 
LIVER 
 
 
 37.20 ± 5.419 
   
13.630±2.403a 
 
27.723±4.481c 
   
38.546±5.413c
 
KIDNEY 
 
31.244±6.419 
 
15.825±3.408a 
 
19.438±3.682 
 
29.758±4.019c
 
GPx 
(U/mg 
protein) 
 
LIVER 
     
10.044±1.094 
    
7.149±1.036a 
    
8.979±0.903d 
   
10.026±0.639c
 
KIDNEY 
     
10.514±1.269 
    
6.754±1.090a 
 
 8.176±0.477 
  
10.212±0.954c
 
LPO 
(MDA in 
nmol/mg. 
Protein) 
 
LIVER 
 
 0.257±0.06 
 
0.412±0.07a 
 
0.352±0.045 
 
0.299±0.028d 
 
KIDNEY 
 
0.200±0.051 
 
0.419±0.056a 
 
0.268±0.017c 
 
0.249±0.047c 
 
Values are expressed as mean ± SD for 6 animals; a :- p<0.01 and b :- p<0.05 compared 
to normal ; c:- p<0.01 and d:- p<0.05 compared to control. 
 
 
Evaluation of the chemoprotective activity of 70% methanolic extract of Gmelina arborea stem bark against 
cyclophosphamide induced toxicity 
 
RVS College of Pharmaceutical Sciences, Dept. Of Pharmacology, Sulur, Coimbatore.  Page 79 
 
9. EFFECT OF GMELINA ARBOREA STEM BARK EXTRACT ON MICE 
SMALL INTESTINE: 
From the histopathological analysis of the intestine of normal mice it was seen that 
the glands and villi were normal, lined by columnar cells. The muscle layer also appeared 
normal. But the untreated control group administered with cyclophosphamide alone 
showed mucosal damage, hyperplasia of the mucosal glands and villi as well as 
lymphocyte infiltration. The muscle also posses inflammatory changes. Mean while there 
was minimum damage to the intestinal architecture in GALC treated groups compared to 
the control. The intestinal section of GAHC showed normal glands, villi and muscles 
indicating the protective effect of Gmelina arborea stem bark extract against 
cyclophosphamide induced toxicity in mice. 
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Fig:23.  Histopathological analysis of mice small intestine. (A) Normal (B) Control (C) 
GALC -250 mg/kg b.wt (D) GAHC -  500 mg/kg b.wt. Hematoxylin and eosin (H&E) 
staining (40x). 
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8. DISCUSSION 
 
Cancer is one of the most common devastating disease affecting millions of people 
per year around the world. It has been found that cancer is the second leading cause of 
death in humans. 
Cancer results from a series of molecular events that fundamentally alter the normal 
properties of cells in our body. The normal control systems in cancer cells that prevent 
cell overgrowth and the invasion of other tissues are disabled. Treatment for cancer 
should not begin until the presence of cancer is confirmed by a tissue (i.e., histologic) 
diagnosis. 
Cancer treatment is the series of interventions including psychosocial support, 
chemotherapy, surgery and radiotherapy that is aimed at curing the disease or prolonging 
life considerably while improving the patient’s quality of life. The course of treatment 
depends on the type of cancer, location of cancer and its state of advancement. 
Chemotherapy drugs are toxic compounds that target cells that are growing rapidly. 
Chemotherapy can be used to treat many cancers. More than 100 chemotherapy drugs 
with different mechanism of action are used today, either as single drug or in combination 
with other drugs or treatments. These drugs vary widely in their chemical composition, 
formulation, how they are taken, their effectiveness in treating specific forms of cancer 
and their side effects.  
In this present study cyclophosphamide (CTX) has been used as an anticancer 
agent. Chemoprotective activity of 70 % methanolic extract of Gmelina arborea stem 
bark was studied against the toxicity induced by cyclophosphamide administration. 
Cyclophosphamide is probably the most commonly used alkylating agent. 
Cyclophosphamide administration results in the formation of cross-links with DNA by 
the metabolites produced. Cyclophosphamide undergoes metabolism by microsomal 
enzymes of the cytochrome P450 system to several intermediates with alkylating 
activity. The principal metabolites identified are phosphoramide mustard and acrolein. 
Phosphoramide mustard can undergo dephosphoramidation to yield nitrogen mustard, 
which also has alkylating activity. Metabolites of cyclophosphamide can interact with 
DNA and a protein, resulting in the formation of adducts (Balu et al., 2002). 
Phosphoramide mustard can generate myelosuppression and haemorrhagic cystitis can 
be caused by the acrolein. High dose acute acrolein toxicity produces oxidative stress 
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subsequent to the loss of glutathione (GSH) and alkylation reactions at various 
nucleophillic sites in cell-particularly in the nucleaus. Low acrolien doses inhibit cell 
proliferation without affecting viability (Horton N D et al., 1997). The G.arborea 
treated groups were found to show almost normal levels of bone marrow cellularity and 
total WBC count compared to cyclophosphamide treated group thereby illustrating the 
protective effect of G. arborea. The haemoglobin count has no significant difference in 
all the test groups.   
There is pharmacologic evidence that the breakdown of CTX into biologically active 
alkylating compounds takes place principally in the liver (Brock and Hohorst., 1967). As 
a result toxic metabolites which are produced in the liver leads to the toxicity of the liver. 
Hepatic damage is always associated with the cellular necrosis, the increase in tissue lipid 
peroxidation and the depletion in the tissue glutathione (GSH) levels (Sandy and Ben., 
1998). These findings are in agreement with those of the present study, in which there 
was a significant depletion of GSH and a significant increase in lipid peroxides (MDA) in 
liver and kidney tissue homogenates of cyclophosphamide treated control group when. 
While the lipid peroxidation level has been significantly reduced in both liver (p<0.05) 
and kidney (p<0.01) tissues of the Gmelina arborea high dose treated group.  
In order to investigate whether the antioxidant activities of G. arborea  are mediated 
by the increase in antioxidant enzyme activity, we measured SOD and GPx  activities in 
different tissues of mice treated with G. arborea  stem bark extract. In the present study, 
treatment of mice with G. arborea stem bark extract significantly (p<0.01) increased the 
SOD and GPx activities of liver and kidney tissues. 
Liver damage was assessed by biochemical studies such as estimation of serum levels 
of AST, ALT and ALP. Similarly, Merlin and Parthasarathy., 2011 reported the elevation 
of serum levels of many biochemical markers like aspartate transaminase (AST), alanine 
transaminase (ALT), serum alkaline phosphatise (ALP), triglycerides, cholesterol and 
bilirubin. Treatment of mice with cyclophosphamide increased the serum transaminase 
level whereas animals pretreated with G. arborea stem bark extract decreased the 
elevated levels of transaminases (ALT & AST) in a significant manner.  
The excretion of both urea and creatinine depends on the glomerular filtration rate. 
Hence, when damage occurs to the kidney, its values in serum get increased from the 
normal. The present study revealed that, there is a significant increase in the serum 
creatinine and urea level on the animals which is treated with cyclophosphamide alone, 
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Whereas the G. arborea high dose treated group showed a decline in the serum levels of 
Urea and Creatinine in a significant manner (p<0.01). 
Changes in the body weight and organ weight of animals were also analysed during 
the period to find out the toxic effects of cyclophosphamide. Reduction in body weight is 
observed only in control groups. According to Manson and Kang (1994) and Chahoud et 
al., 1999, the body weight alterations are usually observed indicative of toxicity in mice. 
No significant reduction in organ weight was noted except spleen weight. In control 
group animals, reduction in spleen weight was noted when compared to GALC & GAHC 
treated groups. 
In the histopathological studies of small intestine, G. arborea treated groups showed 
no significant structural damage when compared to the cyclophosphamide alone treated 
control group. In this observation it is assumed that G. arborea is highly significant to 
protect the small intestine form cyclophosphamide toxicity. 
These findings clearly demonstrated the chemoprotective activities of G. arborea 
stem bark extract in experimental mice models. 
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9. CONCLUSION 
 
The evidence obtained from the present study indicates that the treatment with extract 
of Gmelina arborea can able to protect the liver and kidney against cyclophosphamide 
induced toxicity. Restoration of serum parameters, tissue antioxidants and haematological 
parameters to its normal value and the reduction in the level of tissue lipid peroxidation 
accounts for the chemoprotective activity of 70% methanolic extract of Gmelina arborea 
stem bark. 
There are number of reports evaluating the phytochemical constituents and 
antioxidant properties of the plant Gmelina arborea. However, the components 
responsible for the chemoprotective activity are currently unclear. Therefore, further 
investigations are needed to be carried out to isolate, identify the compounds present in 
the plant extract and to find out possible mechanism(s) of the protective action of 
Gmelina arborea. 
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